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Abstract: 
 
Nitrite reductase (NiR) is an oxidoreductase enzyme that catalyzes the reduction 
of nitrite (NO2-) to nitric oxide (NO) in the denitrification stage of the nitrogen cycle. To 
study the structure and function of this noncoupled dinuclear copper enzyme, functional 
mimics of NiR were designed by adding a second copper-binding site on the surface of 
the mononuclear copper protein azurin. The existing copper-binding site in azurin is an 
electron transfer (T1) site similar to the T1 center of NiR. This T1 copper center was 
maintained in azurin whereas an additional copper site, a catalytic type 2 (T2) copper site 
similar to the T2 site of NiR was designed using PCR mutagenesis to create the new 
variants with both T1 and T2 copper binding sites. The designed T2 copper site in azurin 
mimics the spectroscopic and functional aspects of native NiR. Four first generation 
azurin variants namely; NiR3His-Az, NiR-Az, PHM-Az and PHM3His-Az were created. 
The reactivity, UV-Vis absorption and electron paramagnetic resonance (EPR) spectra of 
azurin variants showed similarities to that of native NiR. We have further examined the 
nitrite reduction activity of our mimics using the nitrite reduction assays using Griess 
assay system and found that the azurin variants were less active than the native NiR. In 
the attempt to improve the activity of first generation variants, second generation single 
and double mutant variants were created by adding the mutations to the each 1st 
generation variants with modified T1 copper center redox potentials. In addition, 
reduction and re-oxidation rates of the T1 center in the azurin variants were determined 
and were compared with other variants. This yielded insights into the order of the 
reaction between the reducing agent, protein, and the substrate in our mimics. 
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Chapter 1: Introduction 
1.1 The Nitrogen Cycle 
Nitrogen is one of the most important elements in the biology of the earth because 
of its role constituting the important molecules required for the life in earth. Nitrogen is 
the critical limiting element for plant growth and is required for the composition of many 
biologically essential molecules, such as deoxy-ribonucleic acid (DNA), ribonucleic acid 
(RNA), adenosine triphosphate (ATP) and amino acids, the building blocks of protein. 
Nitrogen is the fifth most abundant element in the solar system and makes up 
approximately 79% of the earth’s atmosphere, where it is found in the form of nitrogen 
gas (N2).(1,2,6) 
 Atmospheric nitrogen is inert; hence plants and humans, like other higher 
animals, can’t synthesize these molecules using nitrogen found in the atmosphere. 
Atmospheric nitrogen needs to be reduced and form more reactive species, such as 
ammonium ion (NH4+) and nitrate (NO3-), to be usable by plants and ultimately by 
animals. Plants acquire nitrogen compounds from the soil and water, either deposited by 
nitrogen fixing microorganisms, or from decomposition of plants, animals and waste. 
Humans and other higher animals acquire nitrogen compounds from food. These bio-
available forms of nitrogen further undergo a series of redox reactions to complete the 
nitrogen cycle and recycle atmospheric nitrogen (Fig. 1.1). The nitrogen cycle consists of 
three major processes, namely: nitrogen fixation, nitrification, and denitrification. 
Nitrogen fixation is an anaerobic process in the nitrogen cycle where the splitting 
of inert atmospheric nitrogen molecules and subsequent incorporation of the element into 
ammonium ion (NH4+) take place.(1-3) Although N2 can be cleaved by lightning, 
!
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biological nitrogen fixation is carried out by microorganisms using the enzyme 
nitrogenase. Some prokaryotes such as cyanobacteria, bacteria from genus Azotobacter 
and symbiotic bacteria such as bacteria from genus Rhizobium and Bradyrhyzobium are 
major, well-known nitrogen fixing species.(1,6)  
 
 
 
 
 
 
 
 
 
 
 
 
 
Nitrification is another process in the nitrogen cycle where the oxidation of 
ammonia to nitrate (NO3-) takes place. This oxidation is carried out by nitrifying bacteria 
and provides NO3- in the soil for plant metabolism. In order for NO3- to be incorporated 
into the biomass, reduction to NH3 is necessary.   
Denitrification is the third major stage of the nitrogen cycle where the reduction 
of NO3- takes place. Denitrification takes place in two different pathways; assimilatory 
and dissimilatory denitrification pathways. In assimilatory denitrification, the reduction 
of nitrate to ammonia, known as ammonification or nitrate assimilation, is carried out by 
Fig.!1.1:!Nitrogen!Cycle(3,5)!
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bacteria such as those of the Nitrosomonas family, as well as fungi and plants that use the 
enzyme nitrate reductase.(3,7-9,11)  These enzymes facilitate the reduction of NO3− to NH3 
via assimilation processes, which involve the intermediate production of nitrite 
(NO2−).(5,9,11) 
Although nitrogen assimilation is a central pathway within the nitrogen cycle, it is 
the simpler process that results in ammonia and involves only a few enzymes. 
Dissimilatory denitrification is the more complex pathway in which the stepwise 
reduction of nitrate (NO3−) to N2 occurs. It involves a large number of oxidoreductase 
enzymes to achieve the series of reductions. The first step of dissimilatory reduction is 
the nitrate reductase (NAR) catalyzed reduction of NO3- to NO2-, followed by the nitrite 
reductase (NiR) catalyzed reduction of NO2- to nitric oxide (NO), the nitric oxide 
reductase (NOR) catalyzed reduction of NO to nitrous oxide (N2O) and finally the nitrous 
oxide reductase (N2OR) catalyzed reduction of N2O to dinitrogen gas (N2) (Fig. 1.2).  
 
 
 
Dissimilatory denitrification is believed to be one of the major sources of nitric 
oxide (NO) and nitrous oxide (N2O) emissions into the atmosphere with a concomitant 
decrease in soil nitrate concentration.(9-11) A wide range of bacteria and archea can 
perform denitrification, using a variety of enzymes.  
Fig. 1.2: Dissimilatory reduction of nitrite to dinitrogen gas. (9) 
!
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1.2 Nitrite Reductase (NiR) in Nitrogen Cycle 
The family of the enzymes that catalyzes the reduction of nitrite (NO2-) to nitric 
oxide (NO) in the first step of the dissimilatory denitrification pathway are 
metalloenzymes called nitrite reductases (NiR). These enzymes have metal ion binding 
active sites that also bind nitrite and in turn form, the reduced nitrogen species NO. Heme 
(Fe) and copper binding enzymes constitute two well-known classes of nitrite 
reductases.(7) Heme c and heme d containing NiRs (cd1-NiR) are bacterial cytochrome 
oxidases (cytochrome cd1) found mainly in Pseudomonas aeruginosa.(9, 12-14) The copper 
binding nitrite reductases (CuNiR) include coupled copper (Cu-Cu) and non-coupled 
copper (Type 1 Cu, and Type 2 Cu) binding NiRs. CuNiRs are found in many bacterial 
species. Achromobacter cycloclastes(15,16), Hyphomicrobium denitrificans(17), Alcaligenes 
xylosoxidans(18), Alcaligenes faecalis(19) and Rhodobacter sphaeriodes(20,21) are the 
species from which CuNiRs are commonly purified. 
 Three different types of copper containing CuNiRs (or simply NiR), namely 
classes I, II and III, have been characterized so far. Class I and II NiRs consist of three 
identical monomeric subunits (homotrimer) with each subunit containing two non-
coupled copper centers, namely type 1 (T1) and type 2 (T2) (Fig. 1.3). Class I and II 
NiRs differ in the properties of T1 site and their color. Class I NiRs are blue, while Class 
II NiRs are green.(5, 9, 18,19,22) Class I and II NiRs contain one T1 site per monomeric 
unit,(5,9) whereas class III NiR contains two T1 sites per monomeric unit.(23) Class III 
NiRs form a hexamer of monomers.   
!
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Fig. 1.3: Image of green Achromobacter cycloclastes NiR (AcNiR), (PDB ID: 1NIA).(16) 
His$306$
His$95$
Asp$98$
His$135$
Cys$136$
His$145$
Met150$
His$100$
T1$T2$
Fig. 1.4: Active site of AcNiR (PDB ID: 1NIA) where T1 is the electron transfer site and T2 is the 
catalytic site 
!
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The T1 and T2 copper centers of class I and II NiRs are ~12.5 Å apart and non-
coupled electronically. The T1 copper center of NiR binds a Cu(II) ion and serves as an 
electron transfer site, whereas the T2 site is the catalytic site where the reduction of NO2- 
to NO takes place. The T1 site receives the electron from other redox proteins, such as 
azurin and pseudoazurin, and is reduced to Cu(I). It is believed that the electron at the 
reduced T1 site is transferred to the T2 site, which is used for the nitrite reduction.(5,9,24)  
The T1 Cu(II) of NiR is coordinated by two histidines (His95 & His145 (numbers from 
CuNiR of Achromobacter cycloclastes)), one cysteine (Cys136) and one axial methionine 
(Met150) residue (Fig. 1.4).(5,18,19,22-24)  
The color of the blue and green NiRs is due to slight differences in the geometry 
and structural properties of the T1 copper sites and their influence on the ligand to metal 
charge transfer (LMCT) transition between T1 Cu(II) and SCys.(9,25,26) The T1 copper site 
gives a ~600 nm absorption band due to the distorted tetrahedral geometry of the T1 
center giving rise to a dominant S(Cys) pπ → Cu 3d (x2-y2) electronic transition. The 
S(Met) ligand of blue NiR deviates slightly from the axial position of the His-His-Cys 
plane, whereas that of green NIR is in a tilted position and thus changes the geometry 
slightly.(5,25,26) The T1 copper site in green NiR has a flattened tetrahedral geometry 
around the copper ion, giving rise to a dominant S(cys) pσ → Cu 3d (x2-y2) transition 
which gives an increased absorption at 450 nm. (25,26)  
T1 and T2 Cu(II) sites are connected by His135 and Cys136 residues, which 
provide a direct electron transfer pathway from T1 to T2 sites. In addition to the electron 
transferred from T1 site, the reduction of NO2- requires two protons per mole of NO2- as 
shown in the equation below.(24,30,32) 
!
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NO2- + 2H+ + e- !  NO + H2O 
The T2 copper has three histidine residues (His100, His135 and His306) 
coordinated to the copper whereas water or NO2- bind as the fourth ligand. His100 and 
His135 come from same monomeric unit whereas His306 comes from another 
monomeric unit in the trimer. This coordination of copper to the histidines of different 
subunits is believed to keep the monomers bound together. In addition to these three 
histidines, nearby residues Asp98 and His255 are highly conserved residues that are 
believed to play a major role in nitrite binding and catalysis. Asp98 is believed to provide 
one of the two protons required for the reduction of NO2-whereas His255 is believed to 
help create a binding pocket for NO2- in addition to providing the second proton.(5, 24, 28-32, 
34)  
The mechanism of reduction of NO2- by NiR is debated. The first mechanism of 
NiR was proposed by Averill in 1994 and Suzuki et al. proposed an alternative 
mechanism in 2000. These two mechanisms differ in the modes and order of NO2- 
binding to T2 sites (Fig. 1.5). Averill’s mechanism suggests that the electron transfer 
from T1 to T2 takes place first followed by the binding of NO2- to reduced T2 Cu(I). The 
mechanism suggests that NO2- is bound to T2 Cu(I) in η1-N(nitrite) fashion. Once the 
NO2- is bound to the Cu(I), two consecutive proton transfers from nearby residues help 
generate a Cu(I)–NO+ complex, which is in resonance with the corresponding Cu(II)–NO 
radical form. NO is released as a gas from the unstable Cu(II)-NO radical species. (9, 33) 
 
 
 
!
8 
Fig. 1.5: Mechanism of NiR catalyzed reduction of NO2- in T2 site adapted from Averill.(33,9)  
 
 
 
 
 
 
 
 
 
 
 
 
Suzuki et al. used the crystal structure of blue NiR from Alcalagenes xylosoxidans 
(AxNiR) to suggest that the NO2- binds to oxidized T2 copper, Cu(II), in a side-on 
fashion with both oxygens from NO2- binding to the copper. A hydrogen from nearby 
Asp98 residue also helps NO2- bind more tightly by hydrogen bonding with the oxygen of 
NO2- (Fig. 1.6). Once NO2- binds and forms the hydrogen bond, the reduction potential of 
the T2 center increases, making the T1 to T2 site electron transfer spontaneous. The 
presence of the hydrogen bonding allows for the fast formation of an intermediate, 
HONO, which quickly releases NO and forms the oxidized Cu(II) with water bound to 
Cu(II). This mode of NO2- binding is different from Averill’s mechanism which shows 
the N from NO2- binding to the T2 copper.(5,9, 34,35) Suzuki’s mechanism is largely 
supported by the computational studies done by Li et al.(35) and the work done by 
!
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Hasnain et al.(34) but with some differences. Work from Hasnain et al. showed η2-O,O 
nitrite-binding mode to Cu(I) with a short Cu–N bond distance which further suggests 
that the distinct Cu(II)-NO intermediate is formed as opposed to Cu(II)-NO+ as suggested 
by Suzuki et al. (34)   
As the mechanism of native NiR is debated, a few different ways of studying the 
mechanism suw used protein engineering to create a functional mimic of native NiR 
using another electron transfer protein called azurin as a scaffolding.  
 
Fig. 1.6: Mechanism of NiR catalyzed reduction of NO2- adapted from Suzuki et. al. (5) 
!
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1.3 Azurin as a functional mimic of NiR: 
 In addition to the study of native system itself,(5,10-32) researchers have used 
synthetic model complexes,(36,37) computational studies,(34,36) as well as protein 
engineering using other existing proteins as a model.(44,45,47) Protein engineering is a 
viable way of studying the native system by using another protein as a scaffolding to 
model and mimic the functional and/or structural aspects of the native system. We used 
protein engineering to create a functional mimic of native NiR using another electron 
transfer protein called azurin as a scaffolding.  
Azurin is a small (14 kDa) bacterial protein (Fig. 1.7). It is a mononuclear blue 
copper protein in the cupredoxin family containing a T1 Cu(II) binding site. Azurin is an 
oxidoreductase protein purified from Pseudomonas aeruginosa (P.a.) and is thought to be 
the redox partner of native NiR and act as an electron shuttle to its T1 Cu.(5, 39,43) Electron 
transport proteins play key roles in the electron transport chain, photosynthesis and many 
other important biological processes. P.a. azurin in particular, has been used extensively 
for non-native applications, such as a scaffolding to engineer artificial amino acids as 
well as di-copper sites.(44,45,47) It has also been investigated as an anti-cancer agent due to 
its cytotoxic properties, blocking breast cancer cell proliferation by inducing apoptosis.(46) 
The T1 copper-binding site of P.a. azurin is similar to the T1 site of native NiR. 
As in native NiR, T1Cu in azurin is ligated by two histidines (His46 & His117) and one 
cysteine (Cys112) in a trigonal planar geometry. In addition, there are long-range axial 
interactions with methionine (Met121) and a backbone carbonyl oxygen (Gly45 CO) 
(Fig. 1.8).(42) P.a. azurin has 128 amino acids that fold into the common “cupredoxin” or 
Greek-key motif, which is eight antiparallel β-strands in a barrel arrangement similar to 
!
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native NiR. Azurin is a well-characterized cupredoxin family member. In addition to 
having preexisting T1 copper center with similar properties to native NiR, it is a small 
and stable protein that can handle multiple mutations while maintaining its ability to fold 
into a functional protein, which makes azurin an ideal and robust mimic system to design 
a second copper-binding site using protein engineering.[40,41.45,46)  
 
 
To mimic the functional and spectroscopic properties of native NiR, we needed to 
create the T2 binding site similar to that in native NiR. For this purpose, we created 
mimics by designing the secondary copper-binding site (T2 site) on the surface of azurin, 
using QuikChange™ mutagenesis (see Section 1.3.1). The new designed T2 site of azurin 
variants was similar to the T2 site of native NiR. The variants such created were named 
the “first generation variants”. In addition, the electron transfer from T1 to T2 sites in 
Fig. 1.7: Image of Cu(II) bound P.a Azurin 
(PDB: 4AZU).(55) 
His45$
His117$
Met$121$
Cys$112$
T1$
Cu$
Fig. 1. 8: T1 Cu(II) site of Azurin 
(PDB: 4AZU). 
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NiR is believed to take place via a Cys-His direct electron transfer pathway which is not 
present in our mimics. To address that, a direct electron transfer pathway was provided 
by inserting an electron transport amino acid residue between T1 and T2 sites (see 
Section 1.3.2). Next, the reduction potentials of T1 and T2 sites are similar in the native 
NiR whereas our azurin variants were found to have higher reduction potential of T1 site, 
which would make the electron transport from T1 to T2 kinetically unfavorable. The 
reduction potential of T1 site was decreased by mutating certain amino acid residues (see 
Section 1.3.2). These variants with the direct electron transport pathway between T1 and 
T2, as well as with the decreased T1 site reduction potential were called  “second 
generation variants”. Lastly, our variants lack the amino acid residues that attract NO2- or 
create the NO2- binding pocket at T2 site that increases the NO2- affinity. We aim to 
address that by creating the “third generation variants” (not discussed in this Thesis). 
1.3.1 First generation azurin variants to mimic native NiR: 
Four first generation variants were created by incorporating a second copper-
binding site into the antiparallel β-strands 5 and 8 on the surface of azurin. These four 
azurin variants were named NiR-Az, NiR3His-Az, PHM-Az and PHM3His-Az, where 
Az stands for azurin. All four variants were created by conserving the preexisting T1 Cu 
site with a T2 Cu binding site incorporated at ~12 Å away from T1 Cu site. This kept the 
distance between T1 and T2 sites close to that of native NiR (~12.5 Å). The incorporation 
of the T2 center in azurin was achieved by mutating certain amino acid residues using 
QuikChange™ mutagenesis. For the NiR-Az variant, three mutations were made: Asp10 
was mutated to His (Asn10His), Gln14Asp, and Asn16His (Fig. 1.8). Histidines are well 
known copper binding amino acids. By incorporating the Asp residue close to new T2 
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Cu site, it resembled the T2 site of native NiR. Although the NiR-Az variant has a similar 
T2 Cu site to native NiR, it lacks the third histidine, important for providing the proton 
required for the reduction of NO2-. To overcome the issue, NiR3His-Az was prepared by 
mutating all three residues (Asn10, Gln14, and Asn16) to His residue (Fig. 1.9). One of 
the His in the T2 site of native NiR comes from a separate monomeric unit which is not 
available in our small mimic protein.(50)  
The PHM-Az variant is named after another copper binding oxidoreductase 
enzyme peptidylglycine α-hydroxylating monooxygenase (PHM). PHM catalyzes the 
hydroxylation of the alpha carbon of peptidyglycine and generates the final amidated 
peptide product. PHM consists of two copper centers namely CuH and CuM sites. The 
CuM site in PHM is the catalytic site consisting of two histidines and a methionine 
residues ligated to the copper.(48,49) In our PHM-Az mimic, the designed T2 copper site 
mimics the CuM site of native PHM.  In the CuM site of native PHM, the two His ligands 
come from one beta-strand whereas the Met ligand is located by itself between the two 
His ligands on the adjacent strand.(9) PHM-Az was designed by incorporating the 
mutations Gln8Met, Gln14His, and Asn16His (Fig. 1.11) whereas PHM3His-Az was 
designed by mutating all three residues in T2 site of PHM-Az to histidines (Fig 1.12).(50) 
Although the PHM-Az and PHM3His-Az mimics were not designed for nitrite reduction, 
they resemble the Type 2 site in native NiR and hence were similarly tested for nitrite 
reduction. Figures 1.9-1.12 show the cartoon images of the first generation azurin 
variants generated by inserting the theoretical mutations using the software PyMoL. 
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Fig. 1.10: PyMoL generated cartoon image of 
NiR3His-Az. The red circle shows the new 
incorporated T2 site 
His$
His$
His$
Fig. 1.9: PyMoL generated cartoon image of 
NiR-Az. The red circle shows the new 
incorporated T2 site 
His$
His$
Asp$
Fig. 1.12: PyMoL generated cartoon image of 
PHM3His-Az. The red circle shows the new 
incorporated T2 site 
His$
His$
His$
His$
His$
Met$
Fig. 1.11: PyMoL generated cartoon image of 
PHM-Az. The red circle shows the new 
incorporated T2 site 
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1.3.2 Second generation azurin variants: 
Once the first generation variants of azurin were created, their nitrite reduction 
activity was measured. The NiR3His-Az and PHM3His-Az variants (three histidines on 
T2 center) showed higher nitrite reduction activity than the variants with two histidines in 
their T2 centers. The first generation azurin variants only incorporated a copper center 
and did not initially address some aspects of electron transfer chemistry. For example, the 
designed azurin variants lacked the direct electron transfer pathway of T1 Cu(I)-Cys-His-
T2 Cu(II) found in native NiR. The lack of a direct electron transport pathway between 
the T1 and T2 coppers in our system could slow the electron transfer rates.  
A second issue to be addressed was the reduction potential difference between the 
T1 and T2 centers of the designed azurin variants. The reduction potentials of T1 and T2 
Cu centers of native NiR are around 255 ± 3 mV, 244 ± 18 mV respectively.(51) In our 
lab, the reduction potentials of the azurin mimics were measured to be ~350-360 mV  and 
~250-270 mV for T1 and T2 centers respectively (Table 1.1).  
Table 1.1: Reduction potentials of the 1st and 2nd generation azurin variants: 
Variants Reduction potentials 
of T1 site (mV) 
Reduction potentials of 
T2 site (mV) 
*Native AxNiR(51) 255 ± 3 244 ± 18 
†NiR3His-Az 359 ± 5 270 ± 5 
†PHM3His-Az 357 ± 5 258 ± 5 
†NiR-Az 350 ± 5 257 ± 5 
†PHM-Az 353 ± 5 251 ± 5 
††NiR3His-Phe15Trp 359 ± 5 270 ± 5 
††NiR3His-Phe114Pro 269± 8 270 ± 5 
††NiR3His-Met121Gln 269± 8 270 ± 5 
*Reduction potential values from Alcaligenes xylosoxidans (AxNiR) at pH 7.0.(51) 
†Reduction potential values measured in our lab at pH 5.1. 
†† Theoretical reduction potential values based on the values reported previously for the 
same mutations at pH 7.0.(52) 
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There is therefore about a 100 mV difference in the reduction potential of T1 and 
designed T2 center in NiR3His, whereas there is little difference between the native 
copper centers. The larger difference between the copper centers in azurin could affect 
the electron transport rate. Therefore, to address these thermodynamic and kinetic issues 
in electron transport, “second” generation single mutant and double mutant azurin 
variants were created. Second generation variants include all combinations of the 
Phe15Trp (F15W), Phe114Pro (F114P), and Met121Gln (M12Q) mutations. The logic 
behind these mutations will be discussed below. Only these variants of NiR3His-Az will 
be shown here.  
Tryptophan is known to assist in long-range electron transport by electron 
hopping.(54) The Phe15Trp mutation in the azurin mimics inserts a tryptophan residue 
between T1 and T2 copper site providing the possibility of a more direct electron 
transport, which should make the electron transfer between T1 and T2 kinetically favored 
(Fig. 1.13). Phe114Pro and Met121Gln are mutations near the T1 copper center and 
known to decrease the reduction potential by about 90 ± 8 mV.(52,53) In the Phe114Pro 
mutation (Fig. 1.14.), the hydrogen bond between Phe114 and Cys112 is broken which in 
turn frees up Cys112 to move closer to the T1 copper increasing the electron density near 
the copper and thus decreasing the reduction potential.(52,53) In the Met121Gln mutation 
(Fig. 1.15), the carbonyl oxygen from Gln that replaces S from the Met gets closer to the 
T1 copper and increases the electron density around the T1 center reducing the reduction 
potential.(52,53) Figures 1.13-1.15 show the cartoon images of the second generation single 
mutant azurin variants generated by inserting the theoretical mutations using the software 
PyMoL. 
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Fig. 1.13: PyMoL generated cartoon image of NiR3His-F15W azurin variant. 
Trp$
Fig. 1.14: PyMoL generated cartoon image of 
NiR3His-F114P azurin variant. 
Pro$
Fig. 1.15: PyMoL generated cartoon image of 
NiR3His-M121Q azurin variant. 
Gln$
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To further explore the activities of these second generation single mutant variants, 
the mutations were combined by pairing up these three mutations to prepare double 
mutant azurin variants Phe15Trp/Phe114Pro (Fig. 1.16), Phe15Trp/Met121Gln (Fig. 
1.17) and Phe114Pro/Met121Gln (Fig. 1.18) were prepared by adding these mutations to 
NiR3His azurin and the other azurin mimic proteins. These variants were expected to 
have increased nitrite reduction activity by providing an electron transfer wire along with 
the lower reduction potentials. Figures 1.16-1.18 show the cartoon images of the second 
generation double mutant azurin variants generated by inserting the theoretical mutations 
using the software PyMoL. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.!1.16:!PyMoL!generated!cartoon!image!of!NiR3HisBF15W/F114P!azurin!variant!
Pro$
Trp$
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Fig. 1.17: PyMoL generated cartoon image of 
NiR3His-F15W/M121Q azurin variant 
Trp$
Gln$
Fig. 1.18: PyMoL generated cartoon image of 
NiR3His-F114P/M121Q azurin variant 
Gln$
Pro$
 
 
 
 
 
 
 
 
 
 
 
 
Therefore, 7 variants (one 1st generation, three 2nd generation single mutants and 
three 2nd generation double mutants) of each NiR-Az, NiR3His-Az, PHM-Az and 
PHM3His-Az (hence 28 total) variants were created. These variants were characterized 
using spectroscopic methods, such as EPR and UV-Vis spectroscopy. Their nitrite 
reduction activities were also measured. In this thesis, the methods for: (i) protein 
purification, (ii) protein sample preparation for spectroscopic characterization & nitrite 
reduction activity assays and (iii) nitrite reduction assays of these variants will be 
discussed in Chapter 2. The latest results on the kinetics of nitrite reduction and 
discussion of the activity assay will be discussed in Chapter 3. Finally, tangential studies 
on the metal ion exchange properties of T1 Cu(II) wild type azurin will be discussed in 
Chapter 4. 
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Chapter 2: Materials and Methods and spectroscopy 
 
2.1 Azurin Purification: 
The 28 azurin variants discussed in Chapter 1 were created by previous students 
in our lab using Quikchange™ site-directed mutagenesis with previously reported 
protocols.(1-3) The Pseudomonas aeruginosa gene for the production of azurin was coded 
in a pET9a plasmid and the plasmid was transformed into BL21* E coli. The pET9a 
plasmid also contains a kanamycin resistance gene, hence the BL21* E. coli cells were 
grown on LB-agar plates in the presence of 0.05 g/L kanamycin, which allows the 
selective growth of the desired cells. Once the E. coli cells grew on the LB-kanamycin 
plates, a sterile culture tube was prepared with ~8 mL of LB broth. To the sterile culture 
tubes, ~ 2 µL of 0.05 g/L kanamycin stock solution per mL of LB broth was added. The 
cells were transferred and incubated at 37 °C for ~6 hours. Four liters of BactoTM 
tryptone/yeast extract media known as 2xYT was prepared by dissolving 16 g of BactoTM 
tryptone, 10 g of yeast extract and 5 g of NaCl per liter of water. All media were 
sterilized by autoclaving. About 1 mL each of starter culture was transferred into each of 
five flasks containing 0.8 L 2xYT media. About 200 mg of solid kanamycin sulfate was 
dissolved in 5 mL of water and 1 mL was added to each flask. The cells were then 
incubated in a shaker at 30 °C for ~12 hours. After 12 hours of incubation, the gene for 
the production of azurin was induced for ~3 hours with 3 mM isopropyl-beta-D-
thiogalactopyranoside (IPTG). IPTG activates the T7 promoter region of bacteriophage 
T7 RNA polymerase in the BL21* E.coli displacing the repressor on the lac operon. 
When IPTG is added, it results in the overexpression of T7 polymerase, which is able 
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transcribe the pET9a plasmid DNA into RNA. The RNA for azurin is in turn translated to 
make azurin protein. 
 To extract the azurin protein from BL21* E. coli, the pellets were isolated from 
the 2xYT media by centrifuging the cells for ~10 minutes at 7000 rpm at 4°C in an 
Avanti® J-E centrifuge. The cell pellets were then suspended in the 20% sucrose, 1mM 
EDTA, 30 mM tris solution at pH 8.0. The cells were lysed using osmotic shock with 
pure Millipore water and the azurin was extracted. The resulting extracted protein was 
purified using SP-sepharose cation exchange in 50 mM ammonium acetate buffer at pH 
4.10, followed by pH adjustment to 6.35. The protein was concentrated, filtered and 
further purified with and Q-sepharose anion exchange column chromatography, in 50 
mM ammonium acetate buffer at pH 6.35. Typical purification yields were about 30 mg 
azurin per liter of media. The resulting protein was concentrated using Amicon® 
Millipore stirred ultrafiltration cells. These cells concentrate the protein using Millipore 
10,000 normal molecular weight limit (NMWL) Ultracell® YM filter membrane and gas 
pressure (nitrogen gas in our lab) to filter the buffers while retaining azurin in the cell. 
2.2 UV-Vis spectroscopy: 
The concentration of expressed azurin variants was determined by slowly titrating 
the apo-protein with 100 mM CuSO4 until the blue color of azurin, which absorbs at A625 
nm, reached a maximum. The molar absorptivity of wild type azurin (5000 M-1cm-1) was 
used to determine the final concentration. Once the concentration of protein was 
determined, holo-azurin variants were prepared by slowly titrating purified apo-azurin 
variants with 5 eq. of CuSO4 with stirring on ice (4 °C). The samples were left on ice for 
~20 minutes to ensure the complete equilibration of Cu(II) to the T1 and designed T2 
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Fig. 2.1: UV-Vis spectra of first generation variants showing Cu(II) bound to T1 site. 
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copper sites in the protein. As there are only two Cu(II) binding sites, the excess 3 eq. of 
CuSO4 was removed by running 1 mL aliquots of the samples through the PD-10 size-
exclusion desalting column (Sephadex-25 columns from GE Healthcare Life sciences) 
and collection of the protein fraction. These PD-10 columns were also used to accomplish 
final buffer exchange to 50 mM ammonium acetate buffer (pH 5.1). The sample stocks 
such prepared were diluted to ~200 µM and UV-Vis absorption spectra were obtained 
using a Shimadzu UV2401 PC UV-Vis spectrophotometer (Fig. 2.1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
The UV-Vis spectra of the first generation azurin variants (Fig. 2.1) show the 
characteristic blue color, similar to wild type azurin (WT-Az). The absorption band at 
625 nm with Cu(II) bound is due to the S(Cys) ligand to metal charge transfer 
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Fig. 2.2: UV-Vis absorption spectra of NiR3His-Az 2nd generation singe 
mutant variants. 
transition as described in Chapter 1. The UV-Vis spectra of second generation single 
(Fig. 2.2) as well as the double mutant variants  also show the strong absorption band at 
around 625 nm. The Phe114Pro variants had the absorbance band shifted to 600 nm due 
to loss of hydrogen bonding of Phe114 residue to Cys112 residue, whereas Met121Gln 
variants look more greenish in color due to an increase in the absorption band at ~450 
nm. This is a result of the change in geometry and loss of axial interaction from Met121 
residue. Even with these minor spectroscopic changes, the absorption at ~625 nm 
confirms that the T1 site of each of the variants bind Cu(II) to T1 site. 
 
 
 
 
 
 
 
 
 
 
2.3 Electron paramagnetic resonance (EPR): 
Electron paramagnetic resonance (EPR) spectroscopy is a technique that detects 
unpaired electrons. Cu(II) has an electron configuration of [Ar]3d9 and has one unpaired 
electron. Hence it is EPR active. EPR spectroscopy uses microwave energy under an 
applied magnetic field to split the spin state levels of the unpaired electron into high 
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and low energy levels.(7) The difference in energy level of the two electron spin states due 
to the applied magnetic field is reflected in the “g” factor. In addition, the magnetic field 
generated by the spin of copper nucleus gives rise to hyperfine splitting. The energy 
difference between the hyperfine peaks is given by the hyperfine coupling constant (“A” 
factor).(7) The “A” factor depends on the amount of the interaction between the unpaired 
electron and the nucleus. The number of hyperfine peaks in the EPR spectra are 
determined by the nuclear spin and the number of nuclei and is given by the equation 
2nI+1, where “n” is the number of equivalent nuclei, and “I” is the nuclear spin. Since 
the nuclear spin of Cu(II) is 3/2 (I = 3/2), the total number of hyperfine peaks seen per 
Cu(II) nucleus is four.  
EPR can be used to characterize the Cu(II) bound azurin variants. Since the 
electronic environment of T1 and T2 sites are different, they are expected to show 
different EPR parameters. The “g” values are further divided into “gx”, “gy” and “gz” 
which denote the different electronic environments around the copper ion in the x, y, and 
z directions. EPR spectra of azurin variants show the axial symmetry where “gx” and 
“gy” are similar or equivalent due to similar ligand environments and are often referred 
to together as “g⊥”. The “gz” value for Cu(II) azurin is different due to its unique ligand 
in the z direction and also called “g//”. In our azurin variants, four hyperfine peaks are 
seen in the “g//” region. The “g//” value is determined by finding the middle of the 
hyperfine peaks where as the “A//” factor denotes the distance between the hyperfine 
peaks.  The Cu(II) atoms bound to azurin give four hyperfine peaks with distinct A// and 
g// values, which will be presented later in this chapter. 
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  EPR samples were prepared in 50 mM ammonium acetate buffer (pH 5.1). 
Samples with three different Cu(II) loadings were prepared for EPR spectroscopy using 
an azurin variant stock with a concentration more than 0.5 mM. The first type of sample 
had Cu(II) bound to the T1 site and T2 empty (called T1Cu only) to confirm and 
characterize the copper binding at the T1 site in all the azurin variants. T1Cu only 
samples were prepared by slowly titrating CuSO4 to the apo azurin variants with stirring 
on ice. To ensure only the T1 site was populated with Cu(II), only 0.9 eq. of CuSO4 were 
added. Since, the T1 site has stronger affinity for copper, added copper binds to T1 site 
first.  This sample was used to yield the EPR spectra with T1 Cu(II) signals only.  
The second type of EPR sample prepared was T1 with Hg (II) and T2 with Cu(II) 
(called T2 Cu only). Since Hg (II) is EPR silent, these samples were prepared to obtain 
EPR spectra of T2 sites with Cu(II) only. T1 site was first populated by adding 1.5 eq of 
HgCl2 to the protein. The sample was left on ice for ~20 minutes to ensure that all of T1 
sites were filled with Hg (II). The protein was then run through PD-10 desalting columns 
into 50 mM ammonium acetate buffer (pH 5.1) and collected in 300 uL fractions.  The 
fractions containing an A280 nm peak, indicating protein, were collected and the 
concentration of the protein was estimated based on the A280 nm peak using and 
absorptivity of E280 = 8440 M-1 cm-1. To the resulting sample, 0.5 to 0.75 eq. of CuSO4 
were added to bind the T2 center. This way only the T2 site had Cu(II) bound without 
any free copper, and the T1 had Hg (II). 
The third type of EPR sample prepared was azurin variants with both T1 and T2 
Cu(II) ions  (called T1T2 Cu). T1T2 Cu samples were prepared to obtain EPR spectra 
with overlapping T1 and T2 signals of the azurin variants. The samples were prepared 
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by slowly titrating the apo azurin variants with 5 eq. of CuSO4, stirring on ice and left for 
~20 minutes to ensure adequate equilibration. The samples were then passed through PD-
10 columns into 50 mM ammonium acetate buffer (pH 5.1).  
Once the desired copper containing samples were prepared, they were 
concentrated to ~2 mM using the Millipore 10,000 normal molecular weight limit 
(NMWL) Ultracell® YM Centricon centrifugal concentrating device. These centrifugal 
concentrating devices filter the buffers while retaining azurin in the cell. Once 
concentrated, 150 µL of sample was mixed with glycerol in a 1:1 ratio to yield a 300 µL 
total volume of ~1 mM azurin variant. The samples were transferred to EPR sample 
tubes, flash frozen and stored in liquid nitrogen at -196 °C. 
EPR spectra were obtained for first generation mutants (NiR-Az, NiR3His-Az, 
PHM-Az & PHM3His-Az), second generation single mutants (Phe15Trp, Phe114Pro, 
Met121Gln mutants of 1st generation variants) and second generation double mutant 
variants (Phe15Trp/Phe114Pro, Phe15Trp/Met121Gln and Phe114Pro/Met121Gln 
mutants of 1st generation variants) using a Varian E-Line Century Series X-band EPR 
spectrometer in a liquid nitrogen finger dewar at -196 °C. The microwave frequency was 
typically 9.27 GHz with a center field of 3000 gauss. A field width of 1600 gauss was 
scanned over 60 seconds with 2 scans averaged per spectra. A wait time of 10 seconds 
was set between scans with the modulation amplitude set to 5 Gauss and a time constant 
of 0.032. Fifteen spectra were obtained for each variant and averaged to get the final 
spectrum. 
The EPR parameters, such as number of hyperfine peaks, their center (“g” values) 
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1.9!2!2.1!2.2!2.3!2.4!2.5!2.6!
g Factor 
Fig. 2.3: EPR spectra of T1 Cu(II) of first generation variants along with the 
simulated spectra predicted by simpow6 overlaid on the top. 
WT-Az (T1) 
NiR-Az (T1) 
NiR3His-Az (T1) 
PHM-Az (T1)
PHM3His-Az!(T1)!
and the distances between hyperfine peaks (“A” values) were obtained using the 
simulation program Simpow6.(4)  
2.3.1 T1, T2 and T1T2 Cu(II) EPR spectra and simulation of 1st generation azurin 
variants: 
Figures 2.3, 2.4 and 2.5 show the EPR spectra and simulated spectra of first and 
generation azurin variants when Cu(II) is bound to T1 site only, T2 site only and both T1 
and T2 sites, respectively. All three T1 Cu(II), T2 Cu(II) and T1T2 Cu(II) EPR spectra 
demonstrate and confirm the copper binding to the respective sites.   
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1.9!2!2.1!2.2!2.3!2.4!2.5!2.6!
g-factor 
PHM-Az 
(T1T2) 
NiR3His-Az 
(T1T2) 
NiR-Az (T1T2) 
PHM3His-Az 
(T1T2) 
Fig. 2.5: EPR spectra of T1T2 Cu(II) of first generation variants along with 
the simulated spectra predicted by simpow6 overlaid on the top. 
1.9!2!2.1!2.2!2.3!2.4!2.5!2.6!
g-Factor 
PHM-Az 
(T2) 
PHM3His-Az 
(T2) 
NiR-Az 
(T2) 
NiR3His-Az 
(T2) 
Fig. 2.4: EPR spectra of T2 Cu(II) of first generation variants along with 
the simulated spectra predicted by simpow6 overlaid on the top. 
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1.9!2!2.1!2.2!2.3!2.4!2.5!2.6!
g Factor 
NiRF15W (T1) 
NiR3HisF15W (T1) 
PHMF15W (T1) 
PHM3HisF15W (T1) 
NiRF114P (T1) 
NiR3HisF114P (T1) 
PHMF114P (T1) 
PHM3HisF114P (T1) 
NiRM121Q (T1) 
NiR3HisM121Q (T1) 
PHMM121Q (T1) 
PHM3HisM121Q (T1) 
Fig. 2.6: EPR spectra of T1 Cu(II) of second generation single mutant variants along 
with the simulated spectra predicted by simpow6 overlaid on the top. Simulations of 
NiRM121Q and PHM3HisM121Q variants are yet to be done. 
2.3.2 T1, T2 and T1T2 Cu(II) spectra and simulation of 2nd generation single mutant 
azurin variants: 
Figures 2.6, 2.7 and 2.8 show the EPR spectra and simulated spectra of second 
generation single mutant azurin variants when Cu(II) is bound to T1 site only, T2 site 
only and both T1 and T2 sites, respectively.  All three T1 Cu(II), T2 Cu(II) and T1T2 
Cu(II) EPR spectra demonstrate and confirm the copper binding to the respective sites.  
(*Note: Single letter abbreviation of the amino acids is used for simplicity. Phe15Trp-Az 
variant is written as F15W, Phe114Pro as F114P and Met121Gln as M121Q) 
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1.9$2$2.1$2.2$2.3$2.4$2.5$2.6$
g Factor 
NIRF15W (T2)  
NIR3HisF15W (T2)  
PHMF15W (T2)  
PHM3HisF15W (T2)  
NiRF114P (T2)  
NiR3HisF114P (T2)  
PHMF114P (T2)  
PHM3HisF114P (T2)  
NiRM121Q (T2)  
NiR3HisM121Q (T2)  
PHMM121Q (T2)  
PHM3HisM121Q (T2)  
Fig. 2.7: EPR spectra of T2 Cu(II) of second generation single mutant variants 
along with the simulated spectra predicted by simpow6 overlaid on the top.  
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1.7!1.9!2.1!2.3!2.5!2.7!2.9! g Factor 
NiRF15W (T1T2) 
NiR3HisF15W (T1T2) 
PHMF15W (T1T2) 
PHM3HisF15W (T1T2) 
NiRF114P (T1T2) 
NiR3HisF114P (T1T2) 
PHMF114P (T1T2) 
PHM3HisF114P (T1T2) 
NiRM121Q (T1T2) 
NiR3HisM121Q (T1T2) 
PHMM121Q (T1T2) 
PHM3HisM121Q (T1T2) 
Fig. 2.8: EPR spectra of T1T2 Cu(II) of second generation single mutant variants along with the 
simulated spectra predicted by simpow6 overlaid on the top. The simulations for NiR-M121Q and 
PHM3His-M121Q variants are yet to be done. 
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1.9$2$2.1$2.2$2.3$2.4$2.5$2.6$
g Factor 
NiRF15W/F114P (T1) 
NiR3HisF15W/F114P (T1) 
PHMF15W/F114P (T1) 
PHM3HisF15W/F114P (T1) 
NiRF15W/M121Q (T1) 
NiR3HisF15W/M121Q (T1) 
PHMF15W/M121Q (T1) 
PHM3HisF15W/M121Q (T1) 
NiRF114P/M121Q (T1) 
NiR3HisF114P/M121Q (T1) 
PHMF114P/M121Q (T1) 
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Fig. 2.9: EPR spectra of T1 Cu(II) of 2nd generation double mutant variants along with the 
simulated spectra predicted by simpow6 overlaid on the top. The simulations for NiR-
F15W/M121Q, NiR3His-F15W/M121Q, PHM-F114P/M121Q, and PHM3His-F114P/M121Q 
variants are yet to be done 
c 
2.3.3: T1, T2 and T1T2 Cu(II) EPR spectra and simulation of 2nd generation double 
mutant azurin variants: 
Figures 2.9, 2.10 and 2.11 show the EPR spectra and simulated spectra of second 
generation double mutant azurin variants when Cu(II) is bound to T1 site only, T2 site 
only and both T1 and T2 sites, respectively.  All three T1 Cu(II), T2 Cu(II) and T1T2 
Cu(II) EPR spectra demonstrate and confirm the copper binding to the respective sites. 
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Fig. 2.10: EPR spectra of T2 Cu(II) of 2nd generation double mutant variants along 
with the simulated spectra predicted by simpow6 overlaid on the top.  
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 Fig. 2.11: EPR spectra of T1T2 Cu(II) of 2nd generation double mutant variants along with the 
simulated spectra predicted by simpow6 overlaid on the top. The simulations for NiR-
F15W/M121Q, NiR3His-F15W/M121Q, and PHM3His-F114P/M121Q variants are yet to be 
done. 
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EPR spectra of each variant confirm the Cu(II) binding to the T1 as well as 
designed T2 sites. The “A” and “g” values of these spectra were determined from the 
simulation program simpow6. These values are summarized in Tables 2.1, 2.2 and 2.3. 
Table 2.1: A// & g// values of T1 and T2 Cu(II) of 1st generation variants:  
Variants T1 T2 
g// A// (Gauss) g// A// (Gauss) 
WT-Az 2.26 55 NA NA 
NiR-Az 2.26 52 2.31 159 
NiR3His-Az 2.26 47 2.29 160 
PHM-Az 2.26 53 2.29 165 
PHM3His-Az 2.26 53 2.30 165  
 
The T1 site of all of the 1st generation azurin variants are similar to wild type 
azurin (WT-Az) and exhibit A// values similar to that of WT-Az (~55 Gauss) whereas T2 
Cu(II) has higher A// (>150 Gauss) and g// (~2.30) values. 
Table 2.2: A// & g// values of T1 and T2 Cu(II) of 2nd generation single mutant variants:  
Variants T1 T2 g// A// (Gauss)  g// A// (Gauss) 
NiR-Phe15Trp 2.25 51.53 2.30 161.5 
NiR3His-Phe15Trp 2.25 53.45 2.29 165.1 
PHMPhe15Trp 2.26 52.82 2.30 163.8 
PHM3His-Phe15Trp 2.26 53.40 2.30 162.7 
NiR-Phe114Pro 2.21 64.9 2.30 154.3 
NiR3His-Phe114Pro 2.21 61.9 2.29 159.7 
PHMPhe114Pro 2.21 63.5 2.29 165.5 
PHM3His-Phe114Pro 2.21 62.5 2.30 164.5 
NiR-Met121Gln - - 2.30 157.3 
NiR3His-Met121Gln 2.29 0 2.27 168.3 
PHM-Met121Gln 2.29 20.7 2.30 164.8 
PHM3His-Met121Gln - - 2.30 163.8 
(Note: The g// and A// values of T1 Cu(II) EPR spectra of NiR-Met121Gln and PHM3His-
Met121Gln (shown as dashes in table 2.2) are not yet determined due to difficulty in 
simulating the spectra.) 
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Table 2.3: A//& g// values of T1 and T2 Cu(II) of 2nd generation double mutant variants:  
Variants 
T1 T2 
g// A// (Gauss)  g// A// (Gauss) 
NiR-Phe15Trp/Phe114Pro 2.20 66.2 2.30 155.8 
NiR3His-Phe15Trp/Phe114Pro 2.20 68.0 2.30 165.1 
PHM-Phe15Trp/Phe114Pro 2.20 67.2 2.30 163.5 
PHM3His-Phe15Trp/Phe114Pro 2.20 68.0 2.30 163.5 
NiR-Phe15Trp/Met121Gln - - 2.30 160.0 
NiR3His-Phe15Trp/Met121Gln - - 2.28 167.6 
PHM-Phe15Trp/Met121Gln 2.29 20.0 2.30 164.3 
PHM3His-Phe15Trp/Met121Gln 2.29 27.6 2.30 163.8 
NiR-Phe114Pro/Met121Gln 2.28 33.9 2.29 156.3 
NiR3His-Phe114Pro/Met121Gln 2.28 37.8 2.28 167.8 
PHM-Phe114Pro/Met121Gln 2.27 39.3 2.30 163.9 
PHM3His-Phe114Pro/Met121Gln - - 2.30 163.8 
(Note: The g// and A// values of T1 and T2 Cu(II) EPR spectra of NiR-
Phe15Trp/Met121Gln, NiR3His-Phe15Trp/Met121Gln and PHM3His-
Phe114Pro/Met121Gln variants (shown as dashes in table 2.3) are not yet determined due 
to difficulty in simulating the spectra) 
 
 The 2nd generation variants show some significant differences from the first 
generation variants. The g// values of the T1 site of Phe114Pro variants are smaller than 
the 1st generation variants (Table 2.2). On the other hand, the g// values of the T1 site of 
Met121Gln variants are larger than the 1st generation variants. These results suggest that 
the change in the atomic environment of T1 center due to Phe114Pro and Met121Gln 
mutations have a significant effect in the g// and A// parameters. The Met121Gln mutation 
in particular changes the shape of EPR spectra of the T1 site from axial to more of a 
rhombic shape. This may be due to the removal of axial interaction of T1 Cu(II) with the 
Met residue changing the T1 site geometry. The Phe15Trp mutation is between the 
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T1 and T2 sites and only shows a minimal impact on the g// values of both the T1 and T2 
sites.   
The g// values of the T2 copper site of our variants are ~2.30 with some variations. 
This value is comparable to the native NiR from Alcaligenes xylosoxidans (AxNiR) 
whose g// value of T2 site is 2.38. (9) The A// values of our variants are larger by 35 gauss 
than A// values of AxNiR and are likely due to lack of the third histidine in theT2 sites of 
our variants.(9)  
2.4 Nitrite reduction Assay with Griess Assay system: 
Once the Cu(II) binding in both T1 and T2 was confirmed, the rate of nitrite 
reduction was measured using kinetic assays, namely the Griess assay and the 
reduction/re-oxidation assays. The methods for the Griess assay and the reduction/re-
oxidation assay will be discussed in detail in this chapter whereas the results for both of 
these kinetic assays will be discussed in Chapter 3. 
The samples for the Griess assay were prepared using the same technique as 
preparing UV-Vis samples, by titrating 5 equivalents of CuSO4 into apo protein and 
removing the excess CuSO4 via PD-10 desalting columns. The buffer was exchanged to 
20 mM potassium phosphate buffer at pH 6.35. In the buffer and pH variation study done 
by previous students in our lab, the assay run with potassium phosphate buffer at pH 6.35 
was shown to have the minimum background activity and highest nitrite reduction 
activity of our NiR3His-Az variant. The concentration of the holo protein was determined 
again using the A625 and the molar absorptivity of azurin (5000 M-1cm-1) and the final 
sample was diluted to 100 µM. The sample was aliquoted out in 260 µL aliquots of 100 
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µM azurin variants in screw cap vials, flash frozen and stored at -80 °C until they were 
used. 
The activity assays were carried out in the inert, N2 and 5% H2 atmosphere in a 
glovebox using a Genesys-10S UV-Vis spectrophotometer. The samples were brought 
into the glovebox, thawed at room temperature, and stirred to allow equilibration in the 
anaerobic conditions for ~20 minutes. Once the samples were equilibrated, 30 µL of 
nitrite stock with 10x concentration of the desired nitrite concentration for the assay were 
added to the azurin variant aliquot (e.g., if 5 mM NO2- was desired for the assay, 30 µL of 
50 mM NO2-
 
was added). The exact amounts and concentrations of the assay conditions 
are summarized in Table 2.4. The resulting nitrite-azurin variants mixture was stirred for 
~5 minutes for complete mixing of nitrite. Since, a constant supply of electrons is 
required to keep T1 and T2 sites reduced and to perform multiple turnovers of nitrite 
reduction, excess (10 µL of 1 M or 333 eq.) ascorbic acid was added (the ascorbic acid 
stock solution pH was also adjusted to 6.35) to the solution in the screw cap vials to 
reduce the protein and initiate the reaction. The final concentrations of each component in 
the screw cap vial were as follows: 33 mM ascorbic acid, azurin 86.7 µM and 1 mM, 5 
mM, 25 mM, 50 mM, 75 mM, 100 mM or 150 mM NO2- concentrations. Time zero was 
recorded as soon as ascorbic acid was added.  The first data point was taken 2 minutes 
after ascorbic acid addition for all concentrations of NO2-. After 2 minutes, 20 µL of the 
reaction mixture was removed from the reaction vial and two serial dilutions in the 20 
mM potassium phosphate buffer were performed to get a 500 µL diluted solution of 0.04 
mM final nitrite concentration. This diluted solution was vortexed for 5 seconds after 
each dilution to ensure a well-mixed solution. In our assays, the concentration of 
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NO2- decreased over time due to the reaction. The concentration of NO2- was monitored  
using the Griess assay. 
 Sulfanilamide (SAN) and N-(1-napthyl)-1-ethylene dihydrochloride (NED) were 
the key colorimetric reagents used for the Griess assay.(8,10,11) SAN and NED were 
prepared and were taken into the glovebox at least 20 mins before the assay was started. 
The concentrations of SAN and NED used were 1% (W/V) and 0.1% (W/V) respectively. 
1% SAN was prepared by dissolving 0.5 g of SAN crystals in 50 mL of 3 M HCl whereas 
0.1% NED was prepared by dissolving 0.05 g of NED powder in 50 mL water.  
To the 500 µL of the diluted assay solution described above, 500 µL of SAN was 
added and the resulting mixture was thoroughly vortexed for 3 seconds. To the solution, 
500 µL of NED was then added as quickly as possible and vortexed for 9 seconds. This 
yields a pink color with a maximum absorbance at 540 nm.  
Upon the addition of SAN to the assay mix containing NO2-, a reaction between 
SAN and NO2- takes place first. An intermediate diazonium salt is produced with the loss 
of a water molecule.(11) When NED is added, it reacts with the diazonium salt 
intermediate and forms an azo compound with pink color that has an maximum 
absorbance at 540 nm (Fig. 2.12). The addition of NED following SAN has to be done 
quickly because ascorbic acid causes interference in the pink color formation by reacting 
with the diazonium salt intermediate. Hence greater sensitivity is achieved when SAN 
addition is followed by the quick addition of NED.(5,6) It takes about 10 minutes to form 
the maximum pink color, hence the A540 nm was measured 10-20 mins after NED addition.  
Data points were removed from the NiR assay every 10 minutes for 1 mM and 5 
mM nitrite concentrations, every 15 minutes for 25, 50 and 75 mM nitrite 
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Fig. 2.12: Reactions involved in the Griess Assay.(8,11) 
 
concentrations, and every 20 minutes for 100 and 150 mM nitrite concentrations. The 
data points were obtained until a ~5% drop in nitrite concentration (5% drop in A540 nm) 
was achieved. The time required for the 5% drop in nitrite concentration was varied 
between 40 minutes and 220 minutes depending upon the variants and the nitrite 
concentration used. The rate of reduction of NO2- in AU min-1 was determined by finding 
the slope of the trendline for the 5% drop in nitrite concentration and corrected for 
dilution by multiplying by the dilution factor. The dilution corrected rates in AU min-1 
were converted to the mM NO2- min-1 by dividing the slope in AU by the absorbance of 
Griess assay complex with unreacted nitrite before the ascorbic acid addition (0.7 AU). 
These assays were done in triplicate and plotted against the corresponding nitrite 
concentrations to get the Michaelis-Menten plots. 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(      ) 
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Table 2.4: Nitrite dilutions for the Griess assay: 
NO2-
concentration 
NO2- addition & 
Data Interval 
Dilutions conditions 
1 mM 
30 µL of 10 mM stock 
added. Data taken 
every 10 minutes 
20 µL of original assay mix diluted into 480 µL of 
buffer, then reacted with SAN and NED to make 
final volume 500 µL. 
5 mM 
30 µL of 50 mM 
stock, Data taken 
every 10 min 
20 µL of original assay mix diluted into 480 µL of 
buffer, then reacted with SAN and NED. After 10 
minutes, 200 µL of pink assay mix was diluted into 
800 µL to make final volume 1 mL. 
25 mM 
30 µL of 250 mM 
stock, Data taken 
every 15 min 
First dilution: 20 µL of original assay mix diluted 
into 480 µL of buffer. Second dilution:  20 µL of 
diluted assay mix further diluted into 480 µL of 
buffer, then reacted with SAN and NED. 
50 mM 
30 µL of 500 mM 
stock, Data taken 
every 15 min 
First dilution: 20 µL of original assay mix diluted 
into 980 µL of buffer. Second dilution:  20 µL of 
diluted assay mix further diluted into 480 µL of 
buffer, then reacted with SAN and NED. 
75 mM 
30 µL of 750 mM 
stock, Data taken 
every 15 min 
First dilution: 20 µL of original assay mix diluted 
into 980 µL of buffer. Second dilution:  20 µL of 
diluted assay mix further diluted into 480 µL of 
buffer, then reacted with SAN and NED. 
100 mM 
30 µL of 1 M stock, 
Data taken every 20 
minutes 
First dilution: 10 µL of original assay mix diluted 
into 490 µL of buffer. Second dilution:  10 µL of 
diluted assay mix further diluted into 490 µL of 
buffer, then reacted with SAN and NED. 
150 mM 
30 µL of 1.5 M stock, 
Data taken every 20 
minutes 
First dilution: 10 µL of original assay mix diluted 
into 490 µL of buffer. Second dilution:  10 µL of 
diluted assay mix further diluted into 490 µL of 
buffer, then reacted with SAN and NED. 
Note: Potassium phosphate buffer (pH 6.35) was used for all of the assays 
• 30 µL of various concentrations NO2- stock was added for all concentrations. 
• The first data point was taken after 2 minutes of ascorbic acid addition for all concentrations. 
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2.5 T1 Cu(II) Reduction/ re-oxidation Assay: 
The reduction and re-oxidation assay is another type of kinetic assay used in our 
lab to understand the mechanism of nitrite reduction by our variants. The reduction/re-
oxidation assay was used to monitor the dependence of nitrite reduction and the electron 
transfer from T1 to T2 Cu(II) site by monitoring the reduction of T1 copper by ascorbic 
acid and the subsequent re-oxidation upon the NO2- binding to T2 site. We used a 
Genesys-10S UV-Vis spectrophotometer in the inert atmosphere in glovebox. Using the 
same method described above for the Griess assay, 0.1 mM protein samples were 
prepared in potassium phosphate buffer at pH 6.35. The samples were degassed in a 50 
mL falcon tube by bubbling with argon gas for 15-20 minutes to reduce oxygen in the 
sample before bringing the sample into the glove box. The samples were incubated for 
~15 minutes in the glovebox with the cap open to let it equilibrate to room temperature 
and the anaerobic environment. Once the samples were equilibrated, 2 mL aliquots of the 
protein were used in a 3 mL, flat bottom cuvette for re-oxidation assays to properly house 
the stir bar for proper mixing. The A625 nm peak was monitored every 2 seconds during the 
entire assay.  
To monitor the initial reduction rates and the dependence of reduction of T1 
Cu(II) on the concentration of reducing agent, various concentrations of ascorbic acid 
were added to the sample while stirring. Ascorbic acid with the final concentration of 
0.05 mM, 0.1 mM, 0.2 mM, 0.5 mM, 0.75 mM and 1 mM (i.e., 0.5-10 eq.) was used. The 
initial rate of reduction of A625 nm peak was monitored. These rates were recorded and 
plotted on y-axis against the ascorbic acid concentration for each mutant, and will be 
presented and discussed in Chapter 3.2. 
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For the re-oxidation reactions, only 1-1.5 eq. of ascorbic acid was added to the 
sample so as to reduce the protein, but not to yield any excess ascorbic acid in solution. 
Once the protein was fully reduced, an appropriate amount of NO2- was added to give a 
final NO2- concentration ranging from 1 mM to 150 mM. Different concentrations of 
NO2- stock were used to keep the added volume of NO2- under 60 µL so as to minimize 
the protein dilution. Upon the addition of NO2-, the A625 nm started to increase due to the 
re-oxidation of T1 site caused by the electron transfer to T2 site, thus reducing NO2- in 
the process. Since only one eq. of ascorbic acid was added, the re-oxidation shows the 
single turnover of the protein. The rate of re-oxidation was determined by finding the 
slope of the linear region of re-oxidation curve with the largest slope and an R2 value as 
close to 1.00 as possible. The slopes were normalized for the concentration of azurin and 
were plotted against the concentration of NO2- to find the rate constant. These 
experiments were done in triplicate. The re-oxidation reaction results are presented in 
Chapter 3.2.  
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Chapter 3: Enzyme Kinetics !
This chapter will include the results and discussion on the kinetics experiments on the 
nitrite reduction activities of our azurin variants. 
3.1 Michaelis-Menten enzyme kinetics from the Griess assay: 
  
 The azurin variants with T2 Cu(II) were hypothesized to act as an enzyme just 
like NiR and they were tested for their nitrite reduction activities using the Griess assay 
as described in Chapter 2. As explained previously, various nitrite concentrations were 
used as substrate. The Michaelis-Menten enzyme kinetics and its steady-state 
approximation were used as shown in Equation 3.1. The enzyme concentration [E] 
remains constant over multiple turnover cycles of the excess substrate, [S] (i.e. nitrite), 
compared to enzyme concentration [E].(1) When the nitrite is added to the azurin variants, 
it binds to the open ligand-binding site T2 Cu(II) of azurin variants and forms an enzyme 
substrate [ES] product. For our azurin variants to perform multiple turnovers, a 
continuous supply of electrons is necessary for the reduction of T1 and T2 Cu(II) and in 
turn for the reduction of NO2- to NO. Excess (333 equivalents) ascorbic acid was used as 
the source of electrons for multiple turnovers.  
 
 
 
The production of NO as the product using our azurin variants as enzymes was 
confirmed earlier in our lab by the colorimetric test involving the formation of an 
[Fe(NO)(EDTA)]2− complex. The initial rate of nitrite reduction was determined as 
!kr! kcat! (Eq.%3.1)%kf!
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described in the Chapter 2 Methods. The rates were plotted against the corresponding 
nitrite concentrations to get the Michaelis-Menten plots and the Michaelis-Menten 
parameters such as Vmax, Km and turnover number.  
3.1.1 Control with wild type azurin: 
We ran control assays to confirm the reduction of nitrite observed by our designed 
azurin variants was unique. The nitrite reduction assay was attempted at various nitrite 
concentrations with 86 µM wild type azurin, instead of the designed azurin variants, 
prepared in the same fashion as the other variants. The pink color, or absorption at 540 
nm, formed as a result of the Griess testing of aliquots from the reaction (See Chapter 2) 
was monitored over time (Figure 3.1).(3,4) 
 
 
 
 
 
 
 
 
 
 
The initial rate of reduction of nitrite (vo) was determined by running the Griess 
assay for 90 minutes and plotting A540 versus time to find the slope. The initial reduction 
Fig. 3.1: Determination of initial rate of reduction of 5 mM NO2- with 33 mM ascorbic acid 
and 86 µM wild type azurin using Griess assay in 20 mM phosphate buffer at pH 6.35. 
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rate was found to be ~7.5x10-5 AU min-1 (Fig. 3.1) and was therefore considered to be 
negligible. This might be as expected since wild type azurin doesn’t have any solvent 
exposed nitrite-binding sites. The T1 Cu(II) site has all four ligand-binding sites occupied 
by amino acid residues. This control assay confirmed that wild type azurin shows 
minimal nitrite reduction activity, and also that there is negligible direct reaction between 
nitrite and ascorbic acid. We concluded therefore that any nitrite reduction seen with the 
azurin variants is a result of their improved catalytic abilities. The initial reduction rates 
(vo) of azurin were corrected for NO2- concentrations (See Chapter 2.4) and were plotted 
against the corresponding concentration of NO2- to get the Michaelis-Menten plot (Fig. 
3.2). 
 
 
 
 
 
 
 
 
 
The nitrite reduction activity of wild type azurin remained minimal for all 
attempted nitrite concentrations, which suggested that that the Type 1 copper site in wild 
type azurin is not significantly involved in the reduction of nitrite under these conditions. 
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Fig. 3.2: Michaelis-Menten plots for the reduction of NO2- by 86 µM wild type azurin in 
20 mM potassium phosphate buffer at pH 6.35. 
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Fig.!3.3:!Determination!of!initial!rate!of!reduction!of!1!mM!NO2;!with!33!mM!ascorbic!acid!for!86!µM!NiR3His;Az!using!Griess!assay!in!20!mM!phosphate!buffer!at!pH!6.35.!
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3.1.2 Michaelis-Menten kinetics of the first generation variants: 
Assays were also run to determine the Michaelis-Menten kinetics for the first 
generation variants (NiR-Az, NiR3His-Az, PHM-Az and PHM3His-Az). The initial rate 
of reduction (vo) was determined by running the assay until a 5% drop in the 
concentration of NO2- was observed by the Griess assay. An example of the initial rate of 
1 mM nitrite reduction with NiR3His azurin is shown in Fig. 3.3.  
 
 
 
 
 
 
 
 
 
 
The initial reduction of NO2- shows a linear trend for first 5% drop in the 
concentration of NO2-. For 1 mM NO2-, the slope was found to be 7.5x10-4 AU min-1, 
which corresponds to 1.10x10-3 mM nitrite/min. The individual assays for the first 
generation variants were run at nitrite concentrations of 1 mM, 5 mM, 25 mM, 50 mM, 
75 mM, 100 mM and 150 mM. The assay for each concentration was repeated in 
triplicate, and the average and standard deviation was calculated. These rates were then 
plotted versus the corresponding nitrite concentrations for the Michaelis-Menten plots 
shown in Figures 3.4(a)-3.4(d). 
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Fig. 3.4: Michaelis-Menten plots for (a) NiR3His-Az, (b) PHM3His-Az, (c) NiR-Az and (d) PHM-Az 
in 20 mM phosphate buffer at pH 6.35. 
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Fig. 3.5: Compilation of Michaelis-Menten plots for first generation azurin 
variants in 20 mM phosphate buffer at pH 6.35. 
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The azurin variants show significant nitrite reduction activity compared to wild 
type azurin, which showed no nitrite reduction. Among the first generation azurin 
variants, PHM3His-Az and NiR3His-Az had the highest turnover numbers of 9.7x10-3 ± 
1.1x10-3 mM NO2- s-1 mM-1-Az and 9.2x10-3 ± 1.1x10-3 mM NO2- s-1 mM-1-Az, 
respectively. NiR-Az and PHM-Az had the lowest turnover numbers with 5.6x10-3 ± 
1.4x10-3 mM NO2- s-1 mM-1-Az and 6.4x10-3 ± 1.1x10-3 mM NO2- s-1 mM-1-Az, 
respectively. The Km, Vmax and the turnover number were found using the Sigma Plot 
12.5 Enzyme kinetics tool package and are shown in Table 3.1. NiR3His-Az and 
PHM3His-Az have the highest turnover numbers indicating the two variants are most 
efficient at catalyzing nitrite reduction. These quantifiable numbers are consistent with 
the qualitative plots shown in the compilation Fig. 3.5.    
The reason for the varied activities in these four variants is unclear. But we know 
that both PHM-Az and NiR-Az variants lack the third histidine on designed T2 site, 
whereas NiR3His-Az and PHM3His-Az have three histidines, similar to the native 
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NiR. The higher Vmax and turnover numbers of NiR3His-Az and PHM3His-Az may 
reflect the importance of the third histidine. It is assumed that three histidines in the T2 
site bind the copper(II) ion better. The histidines could also play an important role in 
providing the proton necessary for the reduction of NO2-, hence having the third histidine 
is advantageous in our variants as well.  
Table 3.1: Km,Vmax & turnover numbers of 1st generation variants compared to nativeNiR. 
Variants Km  
(mM) 
Vmax  
(mM min-1) 
Turnover Number  
(mM NO2- s-1 mM-1-Az) 
Native AfNiR 53x10-3±5.0x10-3 NA 1.0x103  ± 3.3x101 (2) 
NiR3His-Az 33 ± 11 48x10-3 ± 6.0x10-3 9.2x10-3 ± 1.1x10-3 
PHM3His-Az 46 ± 17 51x10-3 ± 5.9x10-3 9.7x10-3 ± 1.1x10-3 
NiR-Az 36 ± 10 29x10-3 ± 7.5x10-3 5.6x10-3 ± 1.4x10-3 
PHM-Az 55 ± 26 33x10-3 ± 5.6x10-3 6.4x10-3 ± 1.1x10-3 
 
All of these values were compared to the values of native NiR from Alcaligenes 
faecalis (AfNiR).(2) As explained in Chapter 1, 1st generation variants lack either the 3rd 
His or the Asp residue, found near the T2 site of native NiR as well as having ~100 mV 
difference in the reduction potential of T1 and T2. In addition, they also lack the direct 
electron transfer pathway between T1 and T2 sites. It was found that the Km values of our 
variants were 6.2x102 -1.0x103 times bigger than the Km values of native AfNiR showing 
weaker NO2- affinities of our variants. The turnover numbers of our azurin variants were 
about 1.1x105 -1.8x105 times smaller than the native AfNiR. The next goal was to test the 
activity of the second generation single and double mutant variants to see if the added 
mutations (described in Chapter 1) improved the activity. 
3.1.3 Michaelis-Menten kinetics of the NiR3His-Az 2nd generation single mutant variants: 
To characterize the second generation single and double mutant variants, we 
analyzed the activities of variants of one of the most active first generation variant 
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Fig. 3.6: Michaelis-Menten plots for NiR3His-Az second generation single mutant variants (a) 
NiR3His-F15W (b) NiR3His-F114P (c) NiR3His-M121Q and (d) NiR3His-M121L variants in 
20 mM phosphate buffer at pH 6.35. 
 
NiR3His-Az. As explained previously in Chapter 1, Phe15Trp variants have the Phe15 
residue mutated to Trp, which is expected to facilitate the electron transfer between T1 
and T2 sites by providing a direct electron transfer pathway. Similarly, Phe114Pro and 
Met121Gln mutations are expected to increase the electron transfer between T1 and T2 
by reducing the reduction potential of T1 site. All of these variants were hypothesized to 
have improved nitrite reductase activity over the first generation variants. The Michaelis-
Menten kinetics and corresponding parameters were determined using the Griess assay. 
The Michaelis-Menten plots for the second generation single mutant variants of 
NiR3His-Az are shown in Figures 3.6(a) - 3.6(d) and compiled in Figure 3.7.  
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Fig. 3.7: Compilation of Michaelis-Menten plots for NiR3His-Az second generation 
single mutant variants in 20 mM phosphate buffer at pH 6.35. 
 
 
 
 
 
 
 
 
 
 
 
 
The Km, Vmax and the turnover numbers of second generation single mutant 
variants of NiR3His-Az were determined in the same way as in the first generation 
variants and are shown in Table 3.2. 
Table 3.2: Km, Vmax and turnover numbers of 2nd generation single mutant variants of 
NiR3His-Az. 
Variants Km  
(mM) 
Vmax  
(mM min-1) 
Turnover Number  
(mM NO2- s-1 mM-
1Az) 
NiR3His-Az 33 ± 11 48x10-3  ± 6.0 x10-3 9.1x10-3 ± 1.1 x10-3 
NiR3His-Phe15Trp 43 ± 14 65x10-3  ± 8.7x10-3 13x10-3 ± 1.7 x10-3 
NiR3His-Phe114Pro 43 ± 14 55x10-3  ± 6.4x10-3 11x10-3 ± 1.2 x10-3 
NiR3His-Met121Gln 59 ± 19 50x10-3  ± 7.0 x10-3 9.7x10-3 ± 1.3 x10-3 
NiR3His-Met121Leu 23 ± 06 53 x10-3  ± 19x10-3 10x10-3 ± 1.7 x10-3 
NiR3His-Az with 
T1Hg(II), T2Cu(II) 
27± 07 47 x10-3  ± 7.0x10-3 9.1x10-3 ± 1.3 x10-3 
 
  The turnover numbers of NiR3His-Phe15Trp and NiR3His-Phe114Pro are 13x10-
3 ± 1.7 x10-3 mM NO2- s-1 mM-1-Az and 11x10-3 ± 1.2 x10-3mM NO2- s-1 mM-1-Az, 
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respectively, whereas the NiR3His-Met121Gln has the turnover number (9.7 x10-3 ± 1.3 
x10-3 mM NO2- s-1 mM-1-Az) close to that of NiR3His-Az. These numbers are ~6.5x104 
times smaller than the native AfNiR showing a perhaps slightly higher turnover number 
than that of NiR3His-Az (first generation), but this improvement was within the error.  
As a comparison, a new variant, NiR3His-Met121Leu (NiR3HisM121L) was 
tested where the Met121 residue was mutated to Leu. The Met121Leu mutation is known 
to increase the reduction potential of the T1 site.(5)  Met121Leu was expected to function 
in the opposite way as the Met121Gln and Phe114Pro mutations and was hypothesized to 
have lower nitrite reduction activity due to a decreased thermodynamic favorability of 
electron transfer to the T2 site. The Km of the NiR3His-Met121Leu variant was 22.95 
mM, which is the smallest of all of the first and second generation variants whereas the 
turnover number of NiR3HisM121Leu variants (10x10-3 ± 1.7 x10-3 NO2- s-1 mM-1-Az) 
was about the same as the NiR3His-Az. The Km, Vmax and turnover numbers of these 
variants are presented in Table 3.2. The same activity of NiR3His-Az and the second 
generation variants including NiR3His-Met121Leu variant indicates that the electron 
transfer on the second generation variants is not very significant in influencing the rate of 
nitrite reduction. 
Similarly, the second generation single mutant variants of NiR-Az (not NiR3His-
Az) were also tested for their nitrite reduction activities and the results show that these 
variants also showed nitrite reduction activities. The Michaelis-Menten plots for the NiR-
Az second generation single mutant variants are compiled in Fig. 3.8, whereas the Km, 
Vmax and turnover numbers are presented in Table 3.3.  
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Fig. 3.8: Compilation of Michaelis-Menten plots for NiR-Az second generation single 
mutant variants in 20 mM phosphate buffer pH at 6.35. 
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Preliminary results of the second generation single mutant variants of NiR-Az 
variants show comparatively worse Km values than the NiR-Az but show higher turnover 
numbers. NiR-Phe15Trp (13x10-3 ± 2.3x10-3 mM NO2- s-1 mM-1-Az), NiR-Phe114Pro 
(14x10-3 ± 2.8x10-3 mM NO2- s-1 mM-1-Az) and NiR-Met121Gln (9.2x10-3 ± 2.7x10-3 mM 
NO2- s-1 mM-1-Az) show an approximately 2 fold increase in the turnover number, hence 
the improved activity. However, the errors on the Km and turnover numbers of NiR-Az 
second generation variants are significant. More trials of NiR-Az second generation 
single mutant variants need to be done to statistically confirm any improvement on 
activity. 
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Fig. 3.9: Michaelis-Menten plot of NiR3His-Az variant with T1 Hg(II) and T2 
Cu(II) in 20 mM phosphate buffer at pH 6.35 
 
Table 3.3: Km, Vmax and turnover numbers of second generation single mutant variants of 
NiR-Az. 
Variants Km  
(mM) 
Vmax  
(mM min-1) 
Turnover Number 
(mM NO2- s-1 mM-1Az) 
NiR-Az 36 ± 1 29x10-3 ± 4.0x10-3 5.6x10-3 ± 0.7x10-3 
NiR-Phe15Trp 95 ± 19 69x10-3 ± 21x10-3 13x10-3 ± 2.3x10-3 
NiR-Phe114Pro 100 ± 20 73x10-3 ± 8.5x10-3 14x10-3 ± 2.8x10-3 
NiR-Met121Gln 54 ± 12 48x10-3 ± 2.8x10-3 9.2x10-3 ± 2.7x10-3 
 
The data suggest neither changing the reduction potential nor providing a direct 
electron transfer pathway between T1 and T2 in second generation variants has a 
significant effect on the rate of nitrite reduction activity. This suggests that the T1 and T2 
copper centers work independently of each other or the reduction of the T1 and T2 
centers is not the rate determining step on the nitrite reduction. To test this hypothesis, 
NO2- reduction assays were run on the 86 µM NiR3His-Az sample prepared in phosphate 
buffer at pH 6.35 with Hg(II) in the T1 center and Cu(II) in the T2 center. The Michaelis-
Menten plot for the sample such prepared is shown in Figure 3.9.  
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The Km (27 mM) and turnover number (9.1x10-3 mM NO2- s-1 mM-1-Az) of the T1 
Hg(II) T2 Cu(II) sample were comparable to that of NiR3His-Az with Cu(II) on both T1 
and T2 sites, indicating that the variants with T2-Cu(II) only have about the same 
activity, and thus suggest that the transfer of electrons from the T1 to T2 center is not the 
rate limiting step in the activity of our variants. Another possible explanation for no 
improvement on the second generation variants could be negligible electron transfer 
between T1 and T2 sites. The NiR3His-Met121Leu variant that was hypothesized to 
show lower NO2- reduction activity due to thermodynamically unfavored electron transfer 
shows about the same activity as NiR3His-Az and other NiR3His-Az second generation 
single mutant variants indicating the rate of electron transfer may not have rate 
determining step on the NO2- reduction. 
To further explore the effect of the rate of electron transfer rates in the NO2- 
reduction, and hopefully improve the rate of nitrite reduction, the second generation 
double mutant variants were created by pairing up the mutations explained above to make 
double mutants. 
3.1.4 Michaelis-Menten kinetics of the NiR3His-Az second generation double 
mutant variants: 
The second generation double mutant variants were Phe15Trp/Phe114Pro, 
Phe15Trp/Met121Gln and Phe114Pro/Met121Gln variants of 1st generation variants. The 
Phe15Trp/Phe114Pro and Phe15Trp/Met121Gln variants are intended to decrease the 
electron potential of the T1 site as well as provide the electron transfer wire between T1 
and T2 sites. Phe114Pro/Met121Gln variants were meant to lower the reduction potential 
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Fig 3.11 Compilation of Michaelis-Menten plots for NiR3His-Az and its second 
generation double mutant variants in 20 mM phosphate buffer at pH 6.35. 
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of the T1 site by twice the amount of each mutation alone. The Michaelis-Menten plots of 
the second generation double mutant variants are shown in Figures 3.10-3.11.  
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Fig. 3.10: Michaelis-Menten plots for NiR3His second generation double mutant variants (a) 
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The Phe15Trp/Phe114Pro variant of NiR3His-Az was the most active among the 
second generation double mutant variants with lowest Km (31 ± 12 mM) and highest 
turnover number (31x10-3 ± 4.8x10-3 mM NO2- s-1 mM-1-Az), which is ~3 times faster 
than the NiR3His-Az and its second generation single mutant variants. NiR3His-
Phe15Trp/Met121Gln also had high activity, with a turnover number of 26x10-3 ± 7.3x10-
3 mM NO2- s-1 mM-1-Az, which is more than 2.5 times faster than NiR3His-Az and its 
second generation variants while NiR3His-Phe114Pro/Met121Gln variant didn’t show 
much improvement in the activity (11x10-3 ± 1.8x10-3 mM NO2- s-1 mM-1-Az) as it has 
about the same turnover number as the single mutant variants of NiR3His-Az.  
The results show that the nitrite reduction activity of the second generation double 
mutant variants of NiR3His-Az improved significantly from the first and second 
generation single mutant variants but are still ~3x104 to 9x104 times slower than the 
native AfNiR. The Km, Vmax and the turnover number values are summarized in Table 3.4. 
Table 3.4: Km, Vmax and turnover numbers of second generation double mutant variants of 
NiR3His-Az. 
 
The results suggest that the introduction of electron transfer pathway coupled with 
lowering the reduction potential of T1 site have a significant effect on the activity of 
azurin variants. While Phe15Trp variants on the second variants showed just a hint of 
improvement, the improvement was not significant. Adding Phe114Pro and Met121Gln 
Variants Km  
(mM) 
Vmax  
(mM min-1) 
Turnover number 
(mM NO2- s-1 mM-1-
Az) 
NiR3His-Az 36 ± 6.0 48x10-3 ± 4.1x10-3 9.2 x10-3 ± 1.1x10-3 
NiR3HisF15W/F114P 31 ± 12 160 x10-3 ± 43x10-3 31x10-3 ± 4.8x10-3 
NiR3HisF15W/M121Q 74 ± 37 140x10-3 ± 66x10-3 26x10-3 ± 7.3x10-3 
NiR3HisF114P/M121Q 76 ± 19 59x10-3 ± 16x10-3 11x10-3 ± 1.8x10-3 
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mutations on top of the Phe15Trp mutation increase the activity of our variants while 
decreasing the reduction potential of T1 site by two folds the single mutation don’t show 
much improvement on the turnover numbers of first generation NiR3His-Az. 
 The nitrite reduction activities of second generation single and double mutant 
variants of other first generation variants (NiR-Az, PHM-Az and PHM3His-Az) are being 
measured in our lab.  
 
3.2 Single turnover kinetics of first generation azurin variants using reduction/re-
oxidation assays: 
 
3.2.1 Multiple turnovers: 
 Improvement in the activity of second generation double mutant variants suggest 
the T1 copper electron transfer site has an effects on the reaction at T2 catalytic site. 
However, the NiR3His-Az sample with T1 Hg(II) and T2 Cu(II)-only shows nitrite 
reduction almost as fast as NiR3His-Az with both T1 and T2 Cu(II). This led us to 
question the role of the T1 copper site in our mimics, and its effect on the nitrite 
reduction rates. Since the ascorbic acid can likely provide electrons directly to the T2 site 
in addition to T1 site, any electrons the T2 site gains from ascorbic acid alone could 
reduce the NO2-. To probe the relative roles of the T1 and T2 Cu(II) sites, we performed 
single turnover reactions. As explained previously, the T1 copper site has an intense blue 
color that disappears when T1 Cu(II) is reduced to Cu(I) upon addition of 1 eq. of 
ascorbic acid. The blue color can be regenerated when the T1 copper is oxidized to Cu(II) 
with an oxidizing agent, such as nitrite in our experiments. This spectroscopic signature 
of the T1 Cu(II) site was used to monitor a single turnover reaction of our variants. It was 
hypothesized that if electron transfer occurred between the T1 and T2 sites, the blue 
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color of the T1 site would reappear following the addition of NO2- to the reduced protein.  
 First, we tested the stability of our azurin mimics by repeating a single turnover 
experiment multiple times. In the experiment, 100 µM NiR3His-Az sample was prepared 
in 20 mM potassium phosphate buffer at pH 6.35, degassed with argon gas and taken into 
the glovebox following the procedure explained in Chapter 2. When the sample was 
equilibrated, 10 mM NO2- was added to the 2 mL aliquot of the NiR3His-Az sample 
while stirring with the magnetic stir bar. The absorbance at 625 nm was at a maximum 
and did not change with the addition of NO2-, indicating no reaction with the blue 
colored, oxidized form of the enzyme. Then, 2 eq. of ascorbic acid was added to reduce 
the protein. The A625 nm decreased, and with monitoring every 2 s, was observed to return 
quickly, indicating re-oxidation by the presence of NO2-. Upon recovery of A625 nm, 2 
more equivalents of ascorbic acid were added and the A625 nm peak was further monitored. 
This process was repeated multiple times over a 10 hour period (Fig. 3.12). 
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Fig. 3.12: Multiple turnovers of reduction of T1 Cu(II) to Cu(I) with 2 eq. ascorbic acid and 
re-oxidation back to Cu(II) in the presence of NO2- by 100 µM NiR3His-Az. The arrows 
show the point where 2 eq. ascorbic acid was added. 
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Fig. 3.13: (a) Curve showing the reduction of 100 µM NiR3His-Az variant with 0.5 mM ascorbic 
acid. Arrow indicates the point where ascorbic acid was added (b) Determination of first order rate 
constant for the reduction of 100 µM NiR3His-Az with 0.5 mM ascorbic acid (blue) with 1st order fit 
curve in red. 
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The multiple turnover cycles and the full recovery of T1 Cu(II), confirms the 
catalytic nature of our azurin variants. This experiment also demonstrated the robust 
nature of the NiR-mimic catalysts. There was minimal change in recovery of blue color 
upon subsequent turnovers, as well as a full recovery of the azurin solution’s blue color. 
This indicated that the protein was not readily denatured under these conditions and that 
it was capable of catalyzing multiple turnovers.   
3.2.2 Rates of reduction of first generation variants: 
To study the reduction behavior of the azurin variants, and the dependence of 
reduction rates with the concentration of ascorbic acid was monitored. The loss of blue 
color, or A625 nm, of azurin variants upon addition of varying ascorbic acid concentrations 
was monitored with time. The reduction of NiR3His-Az with 0.5 mM ascorbic acid is 
shown in Figure 3.13a, and the first order fit to the reduction, with respect to azurin, is 
shown in Figure 3.13b as a representative example of all azurin variants.  
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The reduction by the reaction of ascorbic acid with azurin was found to be the 
first order with respect to azurin, because, with excess ascorbic acid and limiting azurin 
concentrations, the reduction curves were best fit with a first order exponential function 
(Figure 3.13b and Eq. 3.4). This first order equation was derived from the chemical 
reaction (Eq. 3.2) and its corresponding rate law (Eq. 3.3a). Under excess ascorbate and 
limiting azurin concentration conditions, it can be assumed that the ascorbate 
concentration is essentially constant and therefore a new rate constant k’ (Eq. 3.3c) is 
defined. The resulting rate law (Eq. 3.3b) can be integrated to give the exponential 
function (Eq. 3.4): 
Az (T1Cu2+) + ½ Asc !  Az (T1Cu+) + ½ Asc+     (Eq. 3.2) 
Rate = k[Az][Asc]1/2        (Eq 3.3a) 
 = k’[Az]        (Eq. 3.3b) 
Where,  
k’ = k[Asc]1/2       (Eq. 3.3c) 
 
 [Az] = [Az]o * e-k’t       (Eq. 3.4) 
The resulting rate constants (k’) derived from the fits of Eq. 3.4 to the reduction 
curves (Fig 3.13b) were used to find the order of reaction with respect to ascorbic acid. 
The (k’)’s were plotted against the square root of the ascorbic acid concentrations ranging 
from 0.1 mM to 1 mM according to Eq. 3.3c and shown in Fig. 3.14. A linear fit of the 
(k’)’s with square root of ascorbic acid concentration confirmed the half-order reaction of 
azurin with respect to ascorbic acid. The rate constant k, (in Eq. 3.3a and 3.3c) for the 
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Fig.!3.14:!Plots showing half-order reaction with respect to ascorbic acid for reduction of 
first generation variants.!(a)!NiR3His;Az!(b)!PHM3His;Az!(c)!NiR;Az!(d)!PHM;Az.!
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overall reaction of first generation azurin variants with ascorbic acid was determined by 
finding the slope of the linear fit (Fig. 3. 14). The rate of the reaction between the azurin 
and the ascorbic acid was thus shown to be 1st order rate with respect to the azurin and 
the half-order with respect to the ascorbic acid. 
 
  
 
 
 
 
 
  
 
 
 
 
 
 
 
 
   The overall rate constant (k) for the reaction of azurin with ascorbic acid was 
found to be highest for NiR3His-Az (105x10-2  ± 6.7x10-2 min-1mM-1/2-Az) followed by 
NiR-Az (56x10-2  ± 3.6x10-2 min-1mM-1/2-Az), whereas the rate constants, k, for PHM-
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Az (26x10-2  ± 3.6x10-2 min-1mM-1/2-Az) and PHM3His-Az (32x10-2 ± 2.2x10-2 min-1mM-
1/2-Az) were about the same. These rate constants for the reduction with ascorbic acid for 
the first generation variants are listed in Table 3.5 along with the absolute rates of 
reduction (see below) with 0.5 mM ascorbic acid. 
Table 3.5: The absolute rates of reduction with 0.5 mM ascorbic acid and the rate 
constant, k, of ascorbic acid reduction for the first generation variants. 
Variants 
Absolute rates of reduction 
with 0.5 mM ascorbic acid 
(mM-Az min-1) 
Rate constant, k, for the 
reduction by ascorbic acid 
(min-1 mM-1/2-Asc) 
Wild Type-Az 1.7x10-2 26x10-2 ± 2.1x10-2 
NiR3His-Az 8.3x10-2 105x10-2  ± 6.7x10-2 
PHM3His-Az 2.1x10-2 32x10-2 ± 2.2x10-2 
NiR-Az 4.2x10-2 56x10-2  ± 3.6x10-2 
PHM-Az 2.4x10-2 26x10-2  ± 3.6x10-2 
 
  To compare the absolute rates of reduction of the first generation variants, the 
reaction rate was determined by using the experimentally derived k values in Table 3.5, 
and plugging them into equation 3.3c (or actually the respective best-fit line equations in 
Figure 3.14), following by equation 3.3b, with an azurin concentration of 0.1 mM (100 
µM). The absolute reduction rates of 100 µM of first generation variants with 0.5 mM 
ascorbic acid, in 20 mM potassium phosphate buffer at pH 6.35, are compared and 
summarized in Table 3.5.  
  All of the reduction rates for the variants with a surface T1 copper site are faster 
than WT azurin (1.7x10-2 mM-Az min-1, See chapter 4 for details). However, there is 
some variation among the variants themselves. The rate of reduction of NiR3His-Az with 
0.5 mM ascorbic acid was 8.3x10-2 mM-Az min-1 and was faster than the rest of the first 
generation variants. The initial rates of reduction by 0.5 mM ascorbic acid was found to 
be slower, but about the same for PHM3His-Az (2.1x10-2 mM-Az min-1) and PHM-Az 
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(2.4x10-2 mM-Az min-1). The reduction rate for NiR-Az (4.2x10-2 mM-Az min-1) was 
intermediate between the other variants.  The T1 sites of azurin are conserved in all of 
these variants. So, the varied rates of reduction for these 1st generation variants must be 
due to differences in reactivity of the T2 copper center and indicate that it possibly has a 
role in the reduction. Additionally, for the nitrite reduction assay using the Griess assay, 
the reduction of the azurin variants with ascorbic acid for done with 33 mM ascorbic 
acid. The estimated absolute reduction rate of NiR3His-Az using the linear fit from 
Figure 3.14(a) for the Griess assay (33 mM ascorbic acid), was 6.1x10-2.  In our lab, it 
has been observed that the reduction rate of azurin remains constant for more than 10 
mM ascorbic acid, hence using excess (33 mM) ascorbic acid is indeed a pseudo-first 
order. 
In addition to the reduction rates of T1 site, reduction with 1 equivalent of 
ascorbic acid and the subsequent recovery of blue color (re-oxidation of T1 site) with the 
addition of NO2- was monitored and the rate of re-oxidation were determined (see the 
next Section 3.2.3). The absolute rates of reduction with ascorbic acid, presented above, 
were more than 48 times faster than the re-oxidation rates of T1 Cu(I) to Cu(II) for our 
variants (see next Section 3.2.3, and Section 3.2.4 below) suggesting that the reduction of 
T1 site is not rate limiting step.  
3.2.3 Single turnover re-oxidation of first generation azurin variants: 
To further study the T1 copper site and to confirm the re-oxidation seen in Figure 
3.12 was indeed due to the presence of NO2- and not due to any other oxidizing agents, 
the NiR3His-Az was reduced first with 1 eq. of ascorbic acid. Since each ascorbic acid 
molecule provides two electrons, addition of 1 eq. of ascorbic acid was required to 
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Fig. 3.15: Single turnover of reduction of T1 
Cu(II) of NiR3His-Az with 1 eq. of ascorbic acid 
and re-oxidation with 5 mM NO2- added at 40th 
minute. 
Fig. 3.16: Determination of re-oxidation rate 
of T1 Cu(I) to Cu(II) of NiR3His-Az with 5 
mM NO2- by finding the slope of the most 
linear part. 
 
NO2- added 
reduce both the T1 and T2 copper sites in 1 eq. of azurin variant. Once the protein was 
reduced and remained stably reduced in the glovebox for ~15 minutes, the substrate NO2- 
was added in concentrations ranging from 1-150 mM. With the addition of NO2-, the A625 
nm peak immediately began recovering (Fig. 3.15). Griess test of the reaction confirmed 
that nitrite was being consumed as the azurin re-oxidized.  
The recovery of A625 nm peak upon the addition of NO2- demonstrated that the re-
oxidation of T1 Cu(I) to the Cu(II) state is correlated with the reduction of NO2- on the 
T2 center, since WT azurin with T1 copper alone did not re-oxidize or react with nitrite 
under these conditions. This lent support for the possibility of electron transfer between 
the T1 and T2 centers, since the rates of re-oxidation of the T1 copper center are 
comparable to the rates of nitrite reduction by the Griess assays (see below).   
 
 
 
 
 
 
 
 
 
These re-oxidation assays were repeated for various nitrite concentrations with all 
of azurin variants. The re-oxidation curves were fit to a first-order exponential function 
(not shown here), demonstrating the reaction between the azurin variant and nitrite was 
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Fig. 3.17: pseudo-first order plots for T1 Cu(II) re-oxidation of first generation azurin variants (a) 
NiR3His-Az (b) PHM3His-Az  (c) NiR-Az and (d) PHM-Az. 
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first order with respect to azurin. The rates of re-oxidation were determined, however, by 
measuring the initial slope of the linear part of the re-oxidation curve, typically the first 
1-3 minutes (Fig. 3.16). These rates were plotted versus the corresponding nitrite 
concentrations to find the pseudo-1st order of the reaction between the NO2- and the 
azurin variants and the corresponding rate constant (Fig 3.17). The order of the reaction 
between the azurin variant and nitrite, as well as the rate constant, were found for each of 
the first generation variants (NiR3His-Az, PHM3His-Az, NiR-Az and PHM-Az) as 
shown in Figures 3.17.  
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The order of the reaction was found to be the first order with respect to nitrite. 
The pseudo-first order rate constants for re-oxidation were determined and are 
summarized in Table 3.6. 
Table 3.6: The rate constant of azurin variant T1 Cu(I) re-oxidation with NO2- for the first 
generation variants. 
Variants pseudo-first order re-oxidation rate constant (mM-Az min-1 mM-1-NO2- ) 
NiR3His-Az 23x10-5 ± 6.8x10-5 
PHM3His-Az 7x10-5 ± 1.4x10-5 
NiR-Az 15x10-5 ± 3.9x10-5 
PHM-Az 13x10-5 ± 1.7x10-5 
 
The reduction and re-oxidation of wild-type azurin was also attempted in the same 
way as the first generation variants. Wild type azurin was reduced completely with 0.5 
eq. ascorbic acid at a slower rate (1.7x10-2 mM-Az min-1 for the reduction with 0.5 mM 
ascorbic acid in 20 mM phosphate buffer at pH 6.35) than the other variants. The re-
oxidation of wild type azurin T1 Cu(I) to Cu(II) with NO2- however was not seen (Figure 
not shown) as it lacks the T2 site. This result further suggests that NO2- indeed interacts 
with the T2 site and uses the electron transferred from T1 to T2 site to be reduced to NO 
gas.  
Among the first generation variants, NiR3His-Az (23x10-5 ± 6.8x10-5 mM-Az 
min-1mM-1-NO2-) had the highest pseudo-1st order rate constant for re-oxidation followed 
by NiR-Az (15x10-5 ± 3.9x10-5 mM-Az min-1 mM-1-NO2-), PHM-Az (13x10-5 ± 1.7x10-5 
mM-Az min-1 mM-1-NO2-) and PHM3His-Az (7x10-5 ± 1.4x10-5 mM-Az min-1 mM-1-NO2-
) indicating that NiR3His-Az has the highest dependence on increasing NO2- 
concentration on the re-oxidation rates among the first generation variants, followed by 
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NiR-Az and PHM-Az whereas the PHM3His-Az shows the lowest dependence of 
increasing NO2- concentration on the re-oxidation rates.  
The absolute rates of re-oxidation (not the rate constant) of first generation 
variants were also compared to the initial nitrite reduction rates used for Michaelis-
Menten kinetics, determined by Griess assay, and will be discussed below (see next 
Section 3.2.4).  
3.2.4 Rates of reduction and re-oxidation of the first generation variants, compared 
to Michaelis-Menten rates: 
First of all, the rate of reduction of the T1 Cu(II) to Cu(I) with 1 mM ascorbic 
acid in potassium phosphate buffer at pH 6.35 for NiR3His-Az variant was 120x10-3 
mM-Az min-1 about 73 times faster than the rate of re-oxidation with 1 mM NO2- 
(1.7x10-3 mM-Az min-1). The rate of reduction with 1 mM ascorbic acid was at least 48 
fold (for PHM-Az) faster than the re-oxidation rates with 1 mM NO2- for all of the first 
generation variants. This suggested that the rate-limiting step is not the reduction of the 
enzyme, but rather the reaction with and reduction of nitrite.  
If the reaction of nitrite with the azurin variants was rate limiting, then the rates of 
reduction of nitrite and the rates of re-oxidation of the azurin variants could be similar. 
We compared the absolute rates and found those rates obtained from the nitrite reduction 
assay using the Griess test to indeed be comparable to the rates found with the azurin 
variant re-oxidation assays with nitrite. For example, the initial rates of re-oxidation for 
NiR3His-Az (Fig. 3.17a) were 31x10-4 ± 0.77x10-4 mM-Az min-1 for 5 mM NO2- and 100 
µM NiR3His-Az and are similar to the rates from the nitrite reduction assay using Griess 
test (Fig 3.4a) (38 x10-4 ± 5.3x10-4 mM min-1 for 5 mM NO2- and 86 µM NiR3His-Az).  
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Similar to NiR3His-Az, the NiR-Az and PHM-Az variants also showed similar 
Griess assay rates and re-oxidation rates. For example, the Griess assay rates for 5 mM 
NO2- for NiR-Az (Fig. 3.4c) was 16x10-4 ± 6.7x10-4 mM-NO2- min-1 and the re-oxidation 
rate for same nitrite concentration (Fig. 3.17c) was 11x10-4 ± 2.4x10-4 mM-Az min-1 
whereas the Griess assay rates for 5 mM NO2- for PHM-Az (Fig 3.4d) was 23x10-4 ± 
6.6x10-4 mM-NO2- min-1 whereas the re-oxidation rate for same nitrite concentration (Fig 
3.17d) was 18x10-4 ± 8.3x10-4 mM-Az min-1. The Griess assay and the re-oxidation rates 
were comparable to each other within the errors. The similarity between the Griess assay 
rates and the re-oxidation assay rates was consistent for all of the 1st generation variants 
except for the PHM3His-Az variant. The PHM3His-Az showed smaller re-oxidation rates 
than the Griess assay rates. For example, the Griess assay rate for 5 mM NO2- for 
PHM3His-Az (Fig. 3.4b) was 33x10-4 ± 8.9x10-4 mM-NO2- min-1 whereas the re-
oxidation rate for the same nitrite concentration (Fig. 3.17b) was 14 x10-4 ± 3.5x10-4 
mM-Az min-1; about 2 times smaller than the Griess assay rate.  
The relative rates of the 4 first generation variants were mostly consistent between 
the Griess assays and the re-oxidation assays. Based on Griess assay results, the nitrite 
reduction rates for NiR3His-Az and PHM3His-Az variants were similar and faster than 
those of NiR-Az and PHM-Az (Table 3.1). The same trend is seen in the re-oxidation 
rates, with the exception that PHM3His-Az has a smaller rate. A possible explanation 
could be that the rate of electron transfer from T1 to T2 copper sites in PHM3His-Az 
variant is slower than the other variants causing the slow re-oxidation of T1 Cu(I) to 
Cu(II).  
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The absolute nitrite reduction rates obtained from the Griess assays compared to 
the re-oxidation rates are comparable at low nitrite concentrations, but they deviate at 
high substrate concentrations. The re-oxidation rates show a linear relationship with the 
increasing NO2- concentrations whereas the rates of NO2- reduction with Griess assay are 
asymptotic and level off at the higher NO2- concentrations. This difference in the trend is 
well known because the Michealis-Menten kinetics were obtained under conditions of 
multiple turnovers of NO2- in the presence of excess ascorbic acid with only catalytic 
amounts of the azurin variants. The NO2- reduction rates therefore level off at increasing 
substrate (NO2-) concentration approaching the maximum velocity (Vmax), due to the 
catalytic behavior of the azurin variants that follow the Michaelis-Menten kinetics. On 
the other hand, the re-oxidation of azurin is a non-catalytic process with a single turnover 
of reduction of NO2- by the reduced azurin variants The rate is determined by finding the 
initial slope and single turnover curve hence shows a linear relationship with increasing 
NO2- concentration due to the reaction between nitrite and azurin variants. 
The similarity between the nitrite reduction rates obtained by the Griess assay and 
the re-oxidation rates suggest the rate of electron transfer from T1 to nitrite is comparable 
to the rate of reduction of NO2- at T2 site. This supports the hypothesis that electrons are 
transferred from the T1 to the T2 copper sites during catalysis.  
3.3 Rates of reduction and re-oxidation of NiR3His-Az second generation variants: 
3.3.1 Rates of reduction of second generation single mutant variants: 
The orders of reaction and the rate constant (k) for the reduction of NiR3His-Az 
second generation single mutant variants with various concentrations of ascorbic acid 
was determined in the same way as the first generation variants as explained in Section 
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Fig. 3.18: Plots showing half order reaction with respect to ascorbic acid for 
reduction of NiR3His-Az second generation single mutant variants.  
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3.2.2. The order of reduction of second generation single mutant variants was found to be 
first-order with respect to azurin (fits not shown) and half-order with respect to ascorbic 
acid (Fig. 3.18), which is same as the first generation variants. The overall rate constants 
(k) for the reduction of NiR3His-Az second generation single mutant variants was 
determined by plotting the rate constants (k’) from the first order fit against the square 
root of corresponding ascorbic acid concentrations (Fig. 3.18). These NiR3His-Az 2nd 
generation single mutant variants reduction rate constants are summarized in Table 3.7 
along with their absolute rates of reduction, as calculated in Section 3.2.2. 
 
 
 
 
 
 
 
 
Table 3.7: The absolute rates of reduction and the rate constants (k) of ascorbic acid 
reduction for the NiR3His-Az second generation single mutant variants. 
Variants 
Absolute rate of 
reduction with 0.5 
mM ascorbic acid 
(mM-Az min-1) 
Rate constant, k, for the 
reduction by ascorbic 
acid (min-1 mM-1/2-Asc) 
NiR3His-Az 8.3x10-2 105 x10-2 ± 6.7 x10-2 
NiR3His-Phe15Trp 8.6x10-2 93x10-2 ± 6.9x10-2 
NiR3His-Phe114Pro    2.0x10-2 28 x10-2 ± 1.2x10-2 
NiR3His-Met121Gln 4.8x10-2 71x10-2 ± 1.9 x10-2 
NiR3His-Met121Leu 207x10-2        28 *± 1.6 
*The rate constant for the reduction of NiR3His-Met121Leu was determined by using the (k’) for 0.025 
mM to 0.125 mM ascorbic acid concentration only, as the reduction is faster than we can accurately detect 
at higher concentrations.   
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The rate constants for the reduction (k) were similar but slightly lower than that of 
the parent NiR3His-Azurin. The rate constant was highest for NiR3His-Met121Leu (27 
min-1 mM-1/2-Asc) NiR3His-Phe15Trp (93x10-2 ± 6.9x10-2 min-1 mM-1/2-Asc), followed 
by NiR3His-Met121Gln (71x10-2 ± 1.9 x10-2 min-1 mM-1/2-Asc) whereas NiR3His-
Phe114Pro (28 x10-2 ± 1.2x10-2 min-1 mM-1/2-Asc) had the lowest reduction rate constant 
among the NiR3His-Az 2nd generation single mutant variants. 
  The second generation mutations were originally hypothesized to have faster 
nitrite reduction kinetics, but this was not observed from the Griess assay results. The 
second generation single mutant variants were therefore studied in reduction assays with 
various ascorbic acid concentrations to compare the relative rate reduction between these 
mutants. The absolute rates of reduction upon the addition of 0.5 mM ascorbic acid to the 
100 µM NiR3His-Phe15Trp, NiR3His-Phe114Pro, NiR3His-Met121Gln and NiR3His-
Met121Leu (Figures not shown) variants, in the potassium phosphate buffer at pH 6.35, 
were determined in the same way as in Section 3.2.2. These absolute reduction rates were 
compared between the second generation single mutant variants of NiR3His-Az and 
summarized above in Table 3.7. 
  Among the second generation single mutant variants of NiR3His-Az, the 
NiR3His-Met121Leu variant had the fastest reduction followed by NiR3His-Phe15Trp 
and NiR3His-Met121Gln, whereas NiR3His-Phe114Pro had the slowest reduction rates 
(Table 3.7). The initial reduction rate of NiR3His Phe15Trp was about the same as the 
parent NiR3His-Az whereas the rate of reduction of the NiR3His-Met121Gln and 
NiR3His-Phe114Pro variants were slower than the NiR3His-Az variant in the potassium 
phosphate buffer at pH 6.35. The reduction of the NiR3His-Met121Leu variant with 
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the ascorbic acid however had a faster reduction. The absolute reduction rate of 100 µM 
NiR3His-Met121Leu variant with 0.5 mM ascorbic acid was 207x10-2 mM-Az min-1 
which is ~25 times faster than that of NiR3His-Az (8.3x10-2 mM-Az min-1) with 0.5 mM 
ascorbic acid. The absolute reduction rate of NiR3His-Phe114Pro was found to be    
2.0x10-2 mM-Az min-1; ~4 times slower than that of NiR3His-Az whereas the NiR3His-
Met121Gln was 4.8x10-2 mM-Az min-1; about half the rate of the NiR3His-Az.  The 
reduction rate of NiR3His-Phe15Trp was 8.6x10-2 mM-Az min-1 similar to that of 
NiR3His-Az under the conditions explained above.  
  Possible explanations for these trends in rates of reductions can be correlated with 
the relative reduction potentials of the T1 copper sites in the second generation variants. 
The NiR3His-Phe15Trp variant has a mutation that doesn’t affect the reduction potential 
of T1 site and hence shows a similar reduction rate to that of NiR3His-Az. The NiR3His-
Met121Gln and NiR3His-Phe114Pro mutations lower the reduction potential of the T1 
site (see Chapter 1). This results in the slower observed rates of reduction than those of 
the first generation NiR3His-Az and also 2nd generation NiR3His-Phe15Trp variants as 
the electron affinity of T1 site decreases with the decrease in reduction potential due to 
M121Gln and Phe114Pro mutation. The NiR3His-Met121Leu variant has an increased 
reduction potential at the T1 site, thus causing an increase in the electron affinity of T1 
site. This gave a faster reduction of T1 Cu(II) to Cu(I).  
3.3.2 Re-oxidation rates of second generation variants of NiR3His-Az and NiR-Az: 
The NO2- re-oxidation assays were run with the second generation single mutant 
variants of NiR3His-Az and NiR-Az, as well as the double mutant variants of NiR3His-
Az. As with the first generation variants, the NiR3His-Az and NiR-Az second 
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Fig. 3.19: pseudo-first order plots for re-oxidation of NiR3His-Az 2nd  generation single mutant variants 
(a) NiR3HisF15W (b) NiR3HisM121Q. Re-oxidation was not seen in NiR3HisF114P variant. 
(a) (b) 
generation, single and double mutant variants re-oxidation assays show a 1st order rate 
with respect to the azurin (fits not shown here) and an overall pseudo-first order reaction. 
The pseudo-first order plots of the re-oxidation of T1 Cu(I) to Cu(II) for the single 
mutant variants of NiR3His-Az and NiR-Az were generated by plotting the initial re-
oxidation rates vs the NO2- concentrations as shown in Figures 3.19 and 3.20, 
respectively. The pseudo-first order plots for the re-oxidation of the second generation 
double mutant variants of NiR3His-Az variants were generated in the same way and are 
shown in Figure 3.21. Among the double mutant variants of NiR3His-Az, only NiR3His-
Phe15Trp/Met121Gln variant showed the re-oxidation upon the addition of NO2- (see 
discussion below). 
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Fig. 3.20: pseudo-first order plots for re-oxidation of  NiR-Az second generation single mutant 
variants (a) NiRF15W (b) NiR-M121Q. Re-oxidation was not seen in NiRF114P variant. 
(a) (b) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The rate constants for the re-oxidation of the T1 site of NiR3His-Az and NiR-Az 
2nd generation single and double mutant azurin variants with NO2- are shown in Table 
3.8. 
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Fig. 3.21: pseudo-first order plot for re-oxidation of second generation double mutant 
NiR3HisF15W/M121Q variant. The re-oxidation was not observed in F15W/F114P and 
F114P/M121Q variants.  !
!
77 
Table 3.8: The rate constants of the re-oxidation with NO2- for the second generation 
variants of NiR3His-Az and NiR-Az. 
Variants 
pseudo-first order re-oxidation 
rate constant (mM-Az min-
1mM-1-NO2-) 
NiR3His-Az 23x10-5 ± 6.8x10-5 
NiR3His-Phe15Trp 21x10-5 ± 2.3x10-5 
NiR3His-Met121Gln 16x10-5 ± 0.21x10-5 
NiR-Az 15x10-5 ± 3.9x10-5 
NiR-Phe15Trp 10x10-5 ± 1.0x10-5 
NiR-Met121Gln 15x10-5 ± 1.6x10-5 
NiR3His-Phe15Trp/Met121Gln 14 x10-5 ± 0.57x10-5 
Note: The re-oxidation was not seen in NiR3His-Phe114Pro, NiR3His-Phe15TrpPhe114Pro, NiR3His-
Phe114ProMet121Gln and NiR-Phe114Pro variants (not shown in the table). The re-oxidation assays of 
Met121Leu variant is yet to be done. 
 
  Among the second generation single mutant variants of NiR3His-Az, the 
NiR3His-Phe15Trp (21x10-5 ± 2.3x10-5 mM-Az min-1 mM-1-NO2-) had the highest 
pseudo-1st order re-oxidation rate constant, which was very similar to the parent 
NiR3His-Az variant. The next fastest re-oxidation was by NiR3His-Met121Gln-Az 
(16x10-5 ± 0.21x10-5 mM-Az min-1 mM-1-NO2-), whereas the NiR3His-
Phe15Trp/Met121Gln (14 x10-5 ± 0.57x10-5 mM-Az min-1 mM-1-NO2-) variant shows 
slightly smaller pseudo-1st order re-oxidation rate constant than both NiR3His-Phe15Trp 
or NiR3His-Met121Gln variants.  
  The pseudo-1st order re-oxidation rate constant of fastest NiR3His-Phe15Trp 
variant was similar to that of NiR3His-Az. This is consistent with the Griess assay results 
where the second generation single mutant variants show about the same activity. The 
variants with Met121Gln mutation (i.e. NiR3His-Met121Gln and NiR3His-
Phe15Trp/Met121Gln) variants show slightly smaller pseudo-1st order re-oxidation rate 
constants than the NiR3His-Az and NiR3His-Phe15Trp variants but the difference is not 
significant. This slight difference in the pseudo-1st order rate constant with Met121Gln 
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mutation could be caused by the removal of Met121-T1Cu(II) axial interaction, causing a 
slight decrease in the transfer of the electron between T1 and T2 sites. 
  For the NiR –Az series, the pseudo-1st order re-oxidation rate constants for the 
NiR-M121Gln (15x10-5 ± 1.6x10-5) was within the error of NiR-Phe15Trp (10x10-5 ± 
1.0x10-5). Both of these variants show the similar pseudo-1st order rate constant to that of 
first generation NiR-Az variant (15x10-5 ± 3.9x10-5), further supporting findings from 
Griess assay that shows no improvement in the nitrite reduction activity of the 2nd 
generation single mutant variants. 
  Re-oxidation was not observed in the Phe114Pro variants of NiR3His-Az and 
NiR-Az possibly due to the very slow electron transfer rate between T1 and T2 sites in 
these Phe114Pro variants of NiR3His-Az and NiR-Az (see Section 3.3.3). It was 
observed that even in the absence of ascorbic acid, the blue color started to disappear in 
NiR3His-Phe114Pro variant as soon as NO2- is added. In the Phe114Pro mutation, the 
removal of Phe114-Cys112 hydrogen bond that pushes the Cys112 towards the T1-
copper, could as well create the binding pocket for the nitrite near the T1 site, causing 
further perturbation of T1 site geometry causing the loss of color when the NO2 is added 
to oxidized Phe114Pro variant. This could potentially prevent the electron transfer to T2 
site as well. The absolute re-oxidation rates (not the rate constant) of second generation 
variants were also compared to the absolute nitrite reduction rates obtained by Michaelis-
Menten kinetics analysis by the Griess assay (see the next Section 3.3.3). 
3.3.3 Rates of re-oxidation of the second generation variants, compared to 
Michaelis-Menten rates: 
 
  The re-oxidation rates of NiR3His-Az single and double mutant and NiR-Az 
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single mutant variants were compared with the respective Griess assay rates. We 
hypothesized again that these could be comparable since the rates of reduction by 1 mM 
ascorbic acid were over 48 times faster than the re-oxidation rates with 1 mM NO2-, 
making the reduction of nitrite rate-limiting. For the nitrite reduction with Griess test, 33 
mM ascorbic acid was used. For 33 mM ascorbic acid, the estimated rate of reduction is 
more than 250 times faster than the 1mM NO2- re-oxidation rates, as estimated using the 
equation of best fit from Fig. 3.14. This further supports that the rate-limiting step is not 
the reduction of the azurin variants. The variants with similar re-oxidation and Michaelis-
Menten rates are listed in Table 3.9 whereas the ones that don’t have the similar rates are 
listed in the Table 3.10 (see discussion below for detailed comparison). 
Table 3.9: Comparison of the variants with similar absolute re-oxidation rates to Griess 
rates in phosphate buffer at pH 6.35. 
 
Table 3.10: Comparison of the variants with different absolute re-oxidation rates to 
Griess rates in phosphate buffer at pH 6.35. 
   
Variants with similar re-
oxidation rates to Griess 
assay rates 
Griess assay rates for 
5 mM  NO2-  (mM-
NO2- min-1) 
Re-oxidation assay 
rates for 5 mM  NO2- 
(mM-Az min-1) 
NiR3His-Az 38x10-4 ± 5.3x10-4 31x10-4 ± 0.77x10-4 
NiR-Az 16x10-4 ± 6.7x10-4 11x10-4 ± 2.4x10-4 
PHM-Az 23x10-4 ± 6.6x10-4 18x10-4 ± 8.3x10-4 
NiR3His-Phe15Trp 50x10-4 ± 15x10-4 34x10-4 ± 8.0x10-4 
NiR3His-
Phe15Trp/Met121Gln 49x10
-4 ± 26x10-4 26x10-4 ± 6.2x10-4 
NiR-Phe15Trp 25x10-4 ± 13x10-4 13x10-4 ± 8.0x10-4 
NiR-M121Gln 24x10-4 ± 6.9x10-4 17x10-4 ± 1.0x10-4 
Variants with different re-
oxidation rates to Griess 
assay rates 
Griess assay rates for 5 
mM NO2- (mM-NO2- 
min-1) 
Re-oxidation assay 
rates for 5 mM NO2- 
(mM-Az min-1) 
PHM3His-Az  33x10-4 ± 8.9x10-4 14x10-4 ± 3.5x10-4 
NiR3His-Met121Gln  24x10-4 ± 6.7x10-4 12x10-4 ± 6.7x10-4 
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  As with the parent variants, the rates of re-oxidation were mostly similar and 
could be correlated to the rates of nitrite reduction. The re-oxidation rates of the 
NiR3His-Phe15Trp variant in potassium phosphate buffer at pH 6.35 with 5 mM NO2- 
was similar (34x10-4 ± 8.0x10-4 mM-Az min-1) to that of the Griess assay rates (50x10-4 ± 
15x10-4 mM NO2- min-1) in potassium phosphate buffer at pH 6.35 with 5 mM NO2-. The 
re-oxidation rates of this NiR3His-Phe15Trp is also comparable to the re-oxidation rates 
of parent NiR3His-Az (31x10-4 ± 0.77x10-4 mM-Az min-1, see Table 3.9). This is also 
consistent with the result from the Griess assay for which NiR3His-Phe15Trp showed no 
improvement in the turnover number over the first generation variants.  
  NiR3His-Met121Gln however showed slightly lower re-oxidation rates (12x10-4 ± 
6.7x10-4 mM-Az min-1 for 5 mM NO2-) as compared to the Griess rates (24x10-4 ± 
6.7x10-4 mM NO2- min-1 for 5 mM NO2-). The re-oxidation rate of NiR3His-Met121Gln 
is also slightly smaller than that of NiR3His-Az (Table 3.10) further supporting the lack 
of improvement in the activities on the single mutant variants. The exact reason for the 
difference in the re-oxidation and Griess rates of NiR3His-Met121Gln variant is not yet 
understood but a possible explanation could be that electron transfer between T1 and T2 
sites in the NiR3His-Met121Gln variant is slower than the rate of nitrite reduction.  
  Among the second generation double mutant variants of NiR3His-Az, only the 
Phe15Trp/Met121Gln variant showed the re-oxidation of T1 site. The re-oxidation rate of 
NiR3His-Phe15Trp/Met121Gln with 5 mM NO2- was 26x10-4 ± 6.2x10-4 mM-Az min-1, 
and is within the error from the NO2- reduction rate from the Griess assay. The rate was 
also comparable to the NiR3His-Az (Table 3.9).  
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  For the NiR-Az variant, similarities between the Griess assay rates and the re-
oxidation rates were also observed in the NiR-Phe15Trp variants. The Griess assay rates 
for 5 mM NO2- was 25x10-4 ± 13x10-4 mM-NO2- min-1 whereas the re-oxidation rates 
with 5 mM NO2- was 13x10-4± 8.0x10-4 mM-Az min-1. These rates are within the error of 
each other. The Griess assay rate for NiR-Met121Gln (24x10-4± 6.9x10-4 mM NO2- min-1 
for 5 mM NO2-) was also comparable to the re-oxidation rate (17x10-4 ± 1.0x10-4 mM-Az 
min-1). The re-oxidation rates of NiR-Phe15Trp and NiR-Met121Gln are similar to that of 
the parent NiR-Az (11x10-4 ± 2.4x10-4 mM-Az min-1, see Table 3.10) further confirming 
the similar activities of the first generation and 2nd generation single mutant variant of 
NiR-Az. 
  The re-oxidation of T1 site was not seen for any of the variants containing the 
Phe114Pro mutation. Therefore, the NiR3His-Phe114Pro, NiR3His-
Phe15Trp/Phe114Pro, NiR3His-Phe114P/Met121Gln and NiR-Phe114Pro variants didn’t 
have any recovery of blue color. It was observed that even in the absence of ascorbic 
acid, the blue color started to disappear in NiR3His-Phe114Pro variant as soon as NO2- 
was added. The initial thought was that since the Phe114Pro mutation was intended to 
remove the hydrogen bond between the Phe114 residue and the Cys112 residue, the T1 
Cu(II) could be unstable and fall out when NO2- is added due to chelation of NO2- by T1 
Cu(II). However, the blue color recovered when the NiR3His-Phe114Pro variant sample 
that lost blue color with NO2- addition was oxidized with oxygen outside the glovebox. In 
addition, the blue color didn’t disappear when NO2- was added to the other (NiR3His-
Phe114/ProMet121Gln and NiR3His-Phe15Trp/Phe114Pro) variants suggesting that 
copper doesn’t fall out of the T1 site. Although the blue color doesn’t disappear when 
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only NO2- is added the recovery of blue color with NO2- was not observed on the typical 
timescales with the Phe114Pro variants. The exact reason why the re-oxidation of the T1 
copper doesn’t occur with NO2- in Phe114Pro variants is not yet clear, but the re-
oxidation with oxygen suggests that the re-oxidation is possible. Perhaps the weaker 
oxidizing agent (NO2-) doesn’t have a high enough reduction potential to re-oxidize the 
T1 site. The Phe114Pro variant of NiR3His-Az decreases the reduction potential of T1 
site similar to the Met121Gln variant of NiR3His-Az, thus shifting the equilibrium 
towards the T2 copper center or towards nitrite. In the Phe114Pro mutation, the removal 
of Phe114-Cys112 hydrogen bond that pushes the Cys112 towards the T1-copper, could 
as well create the binding pocket for the nitrite near the T1 site, causing further 
perturbation of T1 site geometry causing the loss of color when the NO2 is added to 
oxidized Phe114Pro variant. This could potentially prevent the electron transfer to T2 site 
as well. It was seen that the re-oxidation rates of NiR3His-Met121Gln variant was slower 
than the Griess reaction rates. A similar mechanism might be taking place in the 
NiR3Hishe114Pro variant while decreasing the rate of electron transfer more than the 
NiR3His-Met121Gln variant. 
3.4: Summary Discussion: 
  We have successfully designed and characterized working mimics of NiR using 
the protein azurin as a scaffold. As the wild type azurin shows minimal to no nitrite 
reduction, each of our 1st and 2nd generation variants show significant nitrite reduction 
activities and also show that electron transport takes place from T1 to T2 sites. Our 
mimic variants show a robust nature and stability that can perform multiple turnovers of 
nitrite reduction. In addition, the 2nd generation double mutant variants show 
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improvement in the activity over the 1st generation variants providing evidence that the 
nitrite reduction activities of these variants can be improved. 
  The improvement in the nitrite reduction activities for the second generation 
double mutant variants with Phe15Trp, as observed in the Michealis-Menten derived 
turnover numbers, was consistent with our hypothesis that a direct electron transport 
pathway between T1 and T2 sites, along with a decreased reduction potential of T1 site 
would improve activity. The lack of improvement in the single mutant activity was 
unexpected. As discussed previously in Section 3.3.3 and also in the Table 3.9 and 3.10, 
the re-oxidation rates among the second generation variants were fastest in the NiR3His-
Phe15Trp variant followed by NiR3His-Met121Gln which re-confirmed the importance 
of the direct electron transfer pathway between T1 and T2 sites for the faster electron 
shuttling. Lowering the reduction potential of T1 site alone (in the Phe114Pro or 
Met121Gln single mutant variants) however doesn’t seem to improve the electron 
transport or the nitrite reduction rates due to the lack of the electron transport pathway 
between T1 and T2 sites. The similarities between the nitrite reduction rates from Griess 
assay and the T1 site re-oxidation assays for most of the variants suggest that the nitrite 
reduction is the rate limiting step. The nitrite reduction could also be affected by the rate 
of electron transport between T1 and T2 sites, which our data suggest is either equal to or 
greater than the nitrite reduction rate, depending on the variant.    
  To understand the mechanism of nitrite reduction in these variants more clearly, 
the NO2- reduction activities from Griess assays as well as the reduction and re-oxidation 
of T1 site of other variants need to be measured. Comparison of these NO2- reduction 
activities along with the reduction and T1 re-oxidation assays with the single and 
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double mutant variants of NiR-Az, PHM-Az and PHM3His-Az could give more insight 
into the role that each mutation plays in the activities of nitrite reduction and re-oxidation 
of T1 site for the azurin variants. In addition, running EPR spectra of the samples, 
especially the ones that don’t show re-oxidation (such as the variants containing 
Phe114Pro mutation) after reduction and attempted re-oxidation with NO2-, could give 
more insight into the presence as well the function of the T1 and T2 copper sites. The 
EPR spectra of these Phe114Pro variants could be used to find whether the T1 and T2 
Cu(II) remain bound to protein or fall out upon the addition of NO2-, which could explain 
why these Phe114Pro variants don’t show the re-oxidation. For these purposes, the nitrite 
reduction assays using the Griess assay along with reduction/re-oxidation assays and the 
ascorbic acid reduction assays of the second generation variants of PHM3His-Az, NiR-
Az, PHM-Az are being done in our lab. Finding the activities of the 2nd generation 
variants of these parent variants could be used to compare the results to the NiR3His-Az 
2nd generation variants to find the pattern in the mutations for different variants. 
  In addition, other factors that could affect the rate of nitrite reduction and give 
insight of the mechanism of our enzymes are being studied in our lab to understand the 
mechanism better. Recently, we are exploring the possibility of the bidirectional behavior 
of our variants that could also catalyze the reverse reaction of nitrite reduction (i.e., 
oxidation of NO to NO2-) to understand the mechanism of our variants better.  
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Chapter 4: Silver(I) and mercury(II) displace Type 1 copper(II) in wild 
type azurin 
 
Prologue: 
 
Chapter 1, 2 and 3 of this thesis were focused on the characterization of the 
engineered azurin variants and comparison of their nitrite reduction activities. While 
performing the initial reduction assays of wild type azurin with ascorbic acid, we noticed 
that the reduction rate of T1 copper is about 50x faster in the presence of 1 eq. extra of 
free Cu(II) than the wild type azurin with no extra Cu(II). This result led us to  
hypothesize that the reduction of free Cu(II) to Cu(I) takes place in the solution first upon 
the addition of ascorbic acid. The Cu(I) then rapidly displaces the T1 Cu(II) causing the 
loss of blue color (or drop of the absorbance peak at 625 nm). This hypothesis was 
further tested with the Ag(I) and Hg(II) exchange studies presented in this chapter. 
Written as a stand-alone chapter, some of the materials from Chapters 1.3, and 2.1-2.3 are 
repeated in sections of this chapter (sections 4.2, 4.3.1 and 4.3.2).   
4.1: Summary:  
Silver (Ag) and mercury (Hg) are well known antimicrobial agents because of 
their cytotoxic properties. Silver in particular has been used as a disinfectant in human 
healthcare since ancient times. Although mercury is not as commonly used in human 
healthcare, it acts as an antimicrobial due to its toxicity. Although silver and mercury are 
cytotoxic to microorganisms, the exact mechanism of cytotoxicity is not well known. 
Pseudomonas aeruginosa (P.a.) azurin is a mononuclear blue copper protein, containing a 
copper(II) ion (Cu(II)) binding site, called a Type 1 (T1) copper site. Although the T1 site 
is primarily a copper binding site, metal ions, such as Ag(I) or Hg(II), can displace the 
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Fig. 4.1:  Structure of P.a. azurin  
(PDB ID: 4AZU). 
Fig. 4.2: T1 Cu(II) site of P.a. azurin, 
PDB ID: 4AZU. 
His46 
His117 
Met121 
Cys112 
Gly45 
redox active Cu(II) from the T1 site. In this study, we explore the active site copper ion 
exchanges with Ag(I) or Hg(II). 
4.2: Introduction:  
Pseudomonas aeruginosa (P.a.) azurin is a mononuclear blue copper protein in 
the cupredoxin family, containing a copper ion (Cu(II)) binding site. Amongst the 
different classes of copper binding sites known in biology, it belongs to the Type 1 (T1) 
copper binding protein family.(1)  P.a. azurin has 128 amino acids that fold into the 
common “cupredoxin” or  Greek-key motif composed of eight antiparallel β-strands in a 
barrel arrangement. The T1 copper binding site functions as the electron transfer site in 
azurin (Fig. 4.1).(2) The T1 center in azurin is supported by two histidines (His46 & 
His117) and one cysteine (Cys112) in a trigonal planar geometry. In addition, there are 
long-range axial interactions with methionine (Met121) and a backbone carbonyl oxygen 
(Gly45 CO) (Fig. 4.2).(6)  
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Azurin is a well characterized “cupredoxin” family member.(1,4,8,11-13) It is a small, 
stable protein that can tolerate multiple mutations, which opens the door to its use as a 
robust mimic system. The oxidized Cu(II) form of azurin has an intense blue color that 
absorbs at 625 nm due to the charge transfer between S(π)Cys and Cu d(x2-y2).(14,15) 
One commonly studied aspect of azurin is its electron transfer properties. Azurin 
is an oxidoreductase protein and is thought to be a redox partner of another copper 
containing enzyme, nitrite reductase (NiR). In bacteria, P.a. azurin is believed to act as an 
electron shuttle in the denitrification pathway.(1,3) Electron transport proteins play key 
roles in the electron transport chain, photosynthesis, and many other important biological 
processes. In addition to electron transfer, P.a. azurin has been used extensively for non-
native applications, such as a mimic scaffold protein or an anti-cancer agent. Azurin was 
used as a scaffold in which to engineer artificial amino acids as well as di-copper sites.(11) 
Azurin was also found to be cytotoxic, blocking breast cancer cell proliferation by 
inducing apoptosis.(8) 
  Azurin is believed to be primarily a copper protein in native systems, however, it 
is also known to bind other metal ions in vitro; silver(I), mercury(II), iron(III), zinc(II), 
nickel(II) and cobalt (II) are reported examples.(10,16-19) Silver (Ag(I)) and mercury 
(Hg(II)), in particular, have high affinity towards azurin.(10) Ag(I) is not believed to be 
biologically essential, and there are no known naturally occurring silver binding proteins. 
Ag(I) is known to be cytotoxic, as is Hg(II). Ag(I) in particular has been known to have 
antimicrobial activity, commonly used against bacteria, mold, and yeast.(5,7) Silver has 
been used as a disinfectant in human healthcare and medicine since ancient times. Use of 
silver nitrate, silver sulfadiazine (SSD) and other silver containing antibiotics for 
!
88 
penicillin and ampicillin resistant bacterial strains, such as P. aeruginosa and S. aereus, 
has led to the development of medical grade and bio-available silver based antibiotics.(9) 
Although, not as commonly used as an antimicrobial due to its high toxicity, Hg(II) is 
also used as a preservative, such as thiomersal, in human vaccines.(9)   
Although the antimicrobial properties of silver salts are well known, the exact 
mechanism of how silver acts as an antimicrobial agent has been debated.(4) One of the 
mechanisms suggested is the displacement of metal ions by Ag(I) ions from various 
proteins. We were interested in studying the activity of Ag(I) and Hg(II) in the 
displacement of Cu(II) from azurin, to test the feasibility of this hypothesis for silver and 
mercury toxicity in microorganisms. In this chapter, recent results on metal ion exchange 
with T1 Cu(II) will be presented. 
 
4.3: Materials and Methods: 
 
In this section, the methods for the study of metal exchange properties of T1 site 
of azurin with Ag(I), Hg(II), Cu(I) and Cu(II) and the results will be discussed. All 
chemicals used in this work were of reagent grade or higher and used without further 
purification. All glassware and media used in cell growths were sterilized by autoclaving.  
4.3.1: Azurin Purification: 
The P.a. gene for the production of azurin was coded in a pET9a plasmid and the 
plasmid was transformed into BL21* E. coli. The pET9a plasmid also contains a 
kanamycin resistance gene, hence the BL21* E. coli cells were grown on LB-agar plates 
in the presence of 0.05 g/L kanamycin, which allows the selective growth of the wild 
type azurin. Once the E. coli cells grew in the LB-kanamycin plates, a sterile culture 
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tube was prepared with ~8 mL volume of LB broth. To the LB broth, ~2 µL of 0.05 g/L 
kanamycin stock solution was added per mL of LB broth in the sterile culture tube. The 
cells were incubated at 37 °C for ~6 hours. Four liters of BactoTMtryptone/yeast extract 
media known as 2xYT was prepared by dissolving 16 g of BactoTM tryptone, 10 g of 
yeast extract and 5 g of NaCl per liter of water. All media were sterilized by autoclaving.  
About 1 mL each of cells grown in LB-broth was transferred into five flasks 
containing 0.8 L each of 2xYT media. About 200 mg of solid kanamycin sulfate was 
dissolved in 5 mL of water and 1 mL each of the kanamycin solution was added to each 
flask containing the 2xYT media and the cells. The cells were then incubated in a shaker 
at 30 °C for ~12 hours. After 12 hours of incubation, the gene for the production of 
azurin was overexpressed for ~3 hours with 3 mM isopropyl-beta-D-
thiogalactopyranoside (IPTG).  IPTG activates the T7 promoter region of bacteriophage 
T7 RNA polymerase in the BL21* E. coli displacing the repressor on the lac operon. 
When IPTG is added, it results in the overexpression of T7 polymerase, which is able 
transcribe the pET9a plasmid DNA into RNA. The RNA for azurin is in turn translated to 
make azurin protein. 
  To extract the azurin protein from BL21* E. coli, the pellets were isolated from 
the 2xYT media by centrifuging the cells for ~10 minutes at 7000 rpm and 4 °C in 
Avanti® J-E centrifuge. The cell pellets were then suspended in the 20% sucrose, 1 mM 
EDTA, 30 mM Tris solution at pH 8.0. The cells were lysed using osmotic shock with 
pure Millipore water at 4 °C and the azurin was extracted. The protein was purified using 
a SP-sepharose cation exchange column in 50 mM ammonium acetate buffer at pH 4.10 
and Q-sepharose anion exchange column chromatography, in 50 mM ammonium 
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acetate buffer at pH 6.35. Typical purification yields were about 30 mg azurin per liter of 
media. The resulting protein was concentrated using Amicon® Millipore stirred 
ultrafiltration cells. The Amicon® concentrates the protein using a filter membrane, and 
gas pressure (nitrogen gas in our lab) to filter the buffer while retaining azurin in the cell. 
4.3.2: UV-Vis and EPR sample preparation: 
 The concentration of expressed azurin was determined by slowly titrating CuSO4 
solution to the apo-protein until the blue color of azurin, which absorbs at A625 nm, 
reached a maximum. The molar absorptivity of wild type azurin (5000 M-1cm-1) was used 
to determine the final concentration. Once the concentration of protein was determined, 
holo-azurin was prepared by slowly titrating 5 eq. of CuSO4 with purified apo-azurin 
with stirring in ice (4 °C). The sample was left on ice for ~20 minutes to ensure the 
complete equilibration of Cu(II) to the T1 site. As there is only one Cu(II) binding site in 
wild type azurin, the excess 4 eq. of CuSO4 was removed by running 1 mL aliquots of the 
samples through the PD-10 size-exclusion desalting column (Sephadex-25 columns from 
GE Healthcare Life sciences) and collection of the protein fraction. These PD-10 
columns were also used to accomplish final buffer exchange to 50 mM ionic strength 
ammonium acetate buffer (pH 5.1). The sample stocks such prepared were diluted to 
~200 µM and UV-Vis absorption spectra were obtained using a Shimadzu UV2401 PC 
UV-Vis spectrophotometer. 
EPR samples were prepared in 50 mM ammonium acetate buffer (pH 5.1) using 
the stock with the concentration of 500-700 µM. The EPR samples were prepared by 
slowly titrating 5 eq. of CuSO4 to the apo azurin, stirring over ice, and left to equilibrate 
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for ~30 minutes. The excess CuSO4 was removed using PD-10 columns as explained 
above for UV-Vis samples.  
EPR spectra were obtained using a Varian E-Line Century Series X-band EPR 
spectrometer in a liquid nitrogen finger dewar at -196 °C. The microwave frequency was 
typically 9.27 GHz with a center field of 3000 gauss. A field width of 1600 gauss was 
scanned over 60 seconds with 2 scans averaged per spectra. A wait time of 10 seconds 
was set between scans with the modulation amplitude set to 5 Gauss and a time constant 
of 0.032. Fifteen spectra were obtained for each variant and averaged to yield the final 
spectrum. Since azurin has T1 Cu(II) site only, EPR spectra showed the signal for T1 
Cu(II) only, with no free copper apparent.  
Further, the reduction of azurin with ascorbic acid, and the dependence of 
ascorbic concentration on the rate of reduction of wild type azurin, was studied. The 
methods for the ascorbic acid reduction assays will be covered in section 4.3.5 and the 
results will be discussed in section 4.4.2. In addition to the reduction assays, the T1 metal 
ion exchange properties of azurin were also studied by preparing holo-azurin samples 
with of either Cu(II), Ag(I) or Hg(II) at the T1 site, and then displacing this T1 metal ion 
with 1 to 5 eq. of either Ag(I), Hg(II) or Cu(I). The detailed methods of these 
experiments will be discussed in the section 4.3.5 and the results will be presented in 
4.4.2 of this Chapter. 
4.3.3: T1 Cu(II) sample preparation for T1 Cu(II) displacement assays: 
The protein samples were prepared with T1 Cu(II) in potassium phosphate buffer 
at pH 6.35 to test the displacement of T1 Cu(II) by other metal ions such as Ag(I), Hg(II) 
and Cu(I). The holo-azurin sample with T1 Cu(II) was prepared by slowly titrating 1 
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eq. CuSO4 solution with apo-azurin with ~20 min equilibration over ice at 4 °C. Any 
extra free CuSO4 was removed by passing holo-azurin through PD-10 desalting columns 
and collecting the blue fraction. These PD-10 columns were also used to accomplish final 
buffer exchange to 20 mM ionic strength potassium phosphate buffer at pH 6.35. The 
concentration of T1 Cu(II) holo-azurin stock was determined and azurin stock was 
diluted to 100 µM to be used for T1 Cu(II) displacement assays (see sections 4.3.5 and 
4.4.2) and also for the Electrospray ionization-Mass spectrometry (ESI-MS) experiments 
(see sections 4.3.6 and 4.4.3) 
4.3.4: T1 Ag(I) and Hg(II) sample preparation for T1 metal ion displacement assays: 
The samples with T1 Ag(I) and T1 Hg(II) were prepared to study the T1 metal ion 
displacement by Cu(I) (sections 4.3.5 and 4.4.2) and also for the ESI-MS experiments 
(sections 4.3.6 and 4.4.3). To prepare the azurin sample with T1 Ag(I), the concentration 
of apo protein stock was determined as described in section 4.3.2. Once the concentration 
was determined, the Ag(I) substituted azurin was prepared by slowly titrating 5 eq. of 
freshly prepared silver nitrate (AgNO3) solution with apo-azurin, followed by 
equilibration for ~30 mins over ice at 4 °C. The A280 nm was measured for the known 
protein concentration. To remove any extra free Ag(I), the Ag(I) bound protein was 
passed through the PD-10 desalting columns and collected in 300 µL fractions. The 
fractions containing an A280 nm peak were collected. The the concentration of the protein 
after removal of excess Ag(I) was estimated based on the ratio of the A280 nm peak before 
and after the removal of excess Ag(I). The assay sample was prepared with a final 
concentration of 100 µM.  
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The 100 µM azurin sample with T1 Hg(II) was prepared with mercuric chloride 
(HgCl2) using the same procedure as T1 Ag(I) preparation. 
4.3.5: T1 reduction and Metal ion exchange assay Methods:  
The azurin samples prepared as explained in sections 4.3.3 and 4.3.4 were 
degassed in a 50 mL falcon tube by bubbling argon gas for 15-20 minutes to minimize 
dissolved oxygen before bringing them into the glovebox. The samples were incubated at 
the room temperature in the glovebox for ~20 minutes to equilibrate with the anaerobic 
conditions.  
To study the reaction of azurin variants with ascorbic acid, the initial reduction 
rate and the dependence of the rate of reduction with various ascorbic acid concentrations 
were determined. The rate and order of the reaction between ascorbic acid and azurin was 
analyzed. In a 3 mL cuvette, a 2 mL aliquot of the azurin with T1 Cu(II) was stirred. To 
the 100 µM azurin sample in 20 mM potassium phosphate buffer at pH 6.35, various 
concentrations of ascorbic acid (0.05 mM, 0.1 mM, 0.2 mM, 0.5 mM, 0.75 mM and 1 
mM, i.e., 0.5 to 10 eq.) were added. The rate of reduction was monitored every 2 seconds 
during the entire assay by monitoring the rate of loss of the A625 nm peak with a Genesys-
10S UV-Vis spectrophotometer. These initial rates of reduction were plotted against the 
corresponding ascorbic acid concentrations to find the order of the reaction and the rate 
constant.  
To study the displacement of T1 Cu(II) by Ag(I), 1 to 5 eq. of a freshly prepared 
AgNO3 solution was added to the holo-Cu(II) azurin sample. The A625 nm peak was 
monitored to see if any displacement of T1 Cu(II) occurred. Similarly T1 Cu(II) was 
displaced from azurin by adding 1 to 5 eq. of HgCl2. The initial rates of Cu(II) 
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displacement were determined by finding the slope of most linear part of the 
disappearance of A625 nm.  
The displacement of T1 Cu(II), Ag(I) or Hg(II) with 1 to 5 eq. Cu(I) was also 
tested in the glovebox. Cu(I) was prepared by pre-reducing CuCl2 with 0.5 eq. ascorbic 
acid, followed by addition to an azurin sample with the appropriate metal ion in T1 site. 
Since azurin with T1 Ag(I) or Hg(II) doesn’t have any color, the rate of displacement 
couldn’t be determined. But, to test the displacement of Ag(I) or Hg(II) with Cu(I), 
samples were oxidized with oxygen and assayed for blue Cu(II)-azurin.  Therefore, the 
samples were stirred and equilibrated for ~30 min after the addition of Cu(I) and were 
run through PD-10 columns to remove excess Cu(I) and displaced Ag(I) or Hg(II). The 
sample was then oxidized with atmospheric oxygen outside the glovebox to see if any 
blue color appeared. The appearance of blue color confirmed the displacement of T1 
Ag(I) or Hg(II) with Cu(I) since the azurin only turns blue when Cu(I) at T1 site oxidizes 
to Cu(II). 
4.3.6: Electrospray Ionization - Mass Spectrometry (ESI-MS): 
 ESI-MS was used to study the metal binding and the displacement of T1 Cu(II), 
with Ag(I), Hg(II) or Cu(I) as well as the displacement of Ag(I) and Hg(II) with Cu(I). 
ESI-MS samples were prepared by adding 5 eq. of the intended metal ion to the apo-
azurin. Excess metal ions were removed using PD-10 desalting columns in 50 mM 
ammonium acetate buffer at pH 5.1. The concentration of T1 Cu(II) sample after buffer 
exchange was determined by measuring A625 nm and using the molar absorptivity of 
azurin (5000 cm-1 M-1) whereas the concentrations of T1 Ag(I) and Hg(II) samples were 
determined using the ratio of A280 nm peak before and after dilution as explained above 
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in section 4.3.4. The samples with final concentration of 300-500 µM were prepared. T1 
metal displacement assays were carried out in the glovebox as discussed in section 4.3.5. 
These assay samples, from section 4.3.5 were analyzed using ESI-MS to study the metal 
loading and metal exchange on T1 site.  
The mass spectra were obtained using a Dionex UltiMate 3000 HPLC in 
combination with a Bruker micrOTOF-Q III mass spectrometer. The electrospray 
ionization (ESI) method was used to gently ionize the samples. The mass spectra were 
deconvoluted to the neutral azurin mass from a minimum of three m/z peaks, typically of 
the +6, +7 and +8 molecular ion peaks. 
 
4.4: Results and Discussion:  
In this section, the results from the EPR and UV-Vis spectroscopy, ascorbic acid 
reduction, the metal exchange assays, as well as the ESI-MS will be discussed. 
4.4.1: UV-Vis absorption and EPR spectra: 
The UV-Vis absorption and EPR spectra of copper(II) bound azurin are shown in 
Figures 4.3 and 4.4.  The T1 Cu(II) bound azurin has a characteristic absorption band at 
625 nm (Fig. 4.3) due to the charge transfer transition between S(π)Cys and Cu d(x2-y2).(14-
15) The EPR spectrum of P.a. azurin shows four hyperfine peaks on the g// region; a 
characteristic of Cu(II), with a g// of ~2.26. The Cu(II) hyperfine coupling constant, A//, 
has a value of ~ 55.3 gauss (Fig. 4.4). The A- and g- values are characteristic of azurin 
and all T1 Cu(II) proteins. 
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Fig. 4.3: Absorbance spectrum of azurin. 
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Fig. 4.4: EPR spectrum of azurin. 
 
 
 
 
 
 
 
 
 
4.4.2: Ascorbic acid reduction, and displacement of T1 Cu(II) in Azurin by Ag(I), 
Hg(II) or Cu(I): 
 The absorbance at 625 nm of Cu(II) bound azurin decreases when it is reduced 
with ascorbic acid in an anaerobic environment. Ascorbic acid is a strong enough 
reducing agent to reduce T1 copper(II) upon addition of 0.5 equivalents (Fig. 4.5) since 
each ascorbic acid molecule provides two electrons.  Presumably, the disappearance in 
color is due to reduction of the protein and not loss of copper. This process is reversible, 
with full recovery of the blue color upon oxygen exposure. The initial rate of reduction of 
azurin with 0.5 eq. ascorbic acid was found to be 0.0071 mM Az min-1 at 100 µM azurin 
concentration in phosphate buffer at pH 6.35.  
The order of reaction of azurin for the reduction with respect to the concentration 
of ascorbic acid was found to be half order with the rate constant of 0.253 min-1 mM-1/2 
ascorbic acid (Fig. 4.6) at constant azurin concentration of 100 µM.  
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Fig. 4.5: Azurin reduction with 0.5eq ascorbic 
acid in phosphate buffer at pH 6.35. 
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Fig. 4.6: Half-order reaction with respect to 
ascorbic acid for reduction of azurin. 
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Interestingly, the rate of reduction of azurin by ascorbic acid increases by an order 
of magnitude when extra Cu(II) is present in the solution with azurin. When 1 eq. of extra 
CuSO4 was added to the T1-Cu(II) azurin sample in anaerobic conditions, the initial rate 
of disappearance of A625 nm upon the addition of 0.5 eq. of ascorbic acid was 0.3501 mM 
Az min-1 which is ~50 times faster than the rate reduction of Cu(II) azurin alone with 0.5 
eq. ascorbic acid (0.00708 mM Az min-1) (Fig. 4.7). We hypothesized that free Cu(II) in 
the solution is first reduced to Cu(I) upon the addition of ascorbic acid by possible rapid 
inner sphere electron transfer upon ascorbic acid and Cu(II) coordination. The Cu(I) may 
then rapidly displace the Cu(II) from T1 site. We thus hypothesized that the rapid 
disappearance of the blue color was due to the exchange of Cu(I) from aqueous solution 
to the sulfur rich azurin active site with the displacement of Cu(II) from azurin into the 
solution. There may also be the slower component of direct reduction of Cu(II) azurin by 
ascorbic acid.  
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Fig. 4.7: Loss of A625 nm with 0.5 eq. ascorbic acid in 
the presence of 1 eq extra Cu(II). Arrow indicates 
the point where ascorbic acid was added. 
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Fig. 4.8: Loss of A625 with 1 eq. Cu(I). The 
arrow indicates the point where 1 eq. extra 
Cu(I) was added.  
 
 
 
 
 
 
 
 . 
 
To further explore the possible rapid displacement of Cu(II) by Cu(I),  1 eq. of 
Cu(I) was added to Cu(II) azurin in an inert atmosphere in 20 mM potassium phosphate 
buffer at pH 6.35. Cu(I) was prepared by pre-incubating 0.5 eq of ascorbic acid with 
Cu(II) salt. Addition of one equivalent of this Cu(I) solution to Cu(II)-azurin resulted in a 
similar fast decrease of the A625 (Fig. 4.8) at  the rate of 0.0510 mM-Az min-1. This is ~7 
times faster than the reduction of T1 Cu(II) azurin alone with 0.5 eq ascorbic acid, but ~7 
times slower than the reduction of Cu(II)-azurin in the presence of excess Cu(II) salt. 
This rate of loss of blue color with the addition of Cu(I) was intermediate between the 
rate of reduction by ascorbate and the rate of color loss in the presence of free copper ion. 
Perhaps this intermediate rate was a result of exclusive metal exchange, with no reduction 
and little to no excess ascorbic acid present. It should be noted that all samples above 
return to their full blue (A625 nm) intensity upon exposure to atmospheric oxygen. 
An alternate explanation for the more rapid loss of blue copper azurin with the 
addition of excess Cu(II) is that Cu(I) participates in more rapid outer sphere electron 
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Fig. 4.9: T1 Cu(II) of azurin displaced with 1 eq. 
AgNO3. The arrow shows the point where AgNO3 
was added. 
Fig 4.10: T1 Cu(II) of azurin displaced with 1 
eq. HgCl2. The arrow shows the point where 
HgCl2 was added. 
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transfer to Cu(II) azurin than ascorbic acid. This mechanism would require no exchange 
of metal ions, but only electron transfer. To test this we attempted Cu(II) displacement 
with other metals.   
 In titrations similar to those with the addition of Cu(I), addition of one equivalent 
of AgNO3 (Fig. 4.9) or HgCl2 (Fig. 4.10) in potassium phosphate buffer at pH 6.35, 
caused a rapid decrease in the absorbance of 625 nm peak. The loss of blue color here is 
presumably due only to the displacement of Cu(II) from the T1 center by the added metal 
ion, since neither Ag(I) or Hg(II) could act as reducing agents under these conditions.  
The rate of disappearance of A625 with 1 eq. AgNO3 was 0.102 mMAz min-1, which is 
about ~14 times faster than direct reduction of Cu(II) azurin with 0.5 eq ascorbic acid, 
and about 2 times faster than the rate of color loss with Cu(I) addition. With 1 eq HgCl2, 
the rate of disappearance of A625 was slower at 0.02 mM-Az min-1, which is still ~2.8 
times faster than the direct reduction by 0.5 eq. ascorbic acid, and about 2.5 times slower 
than color loss by Cu(I) (Table 4.1).  
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Another interesting observation is that the addition of 1 eq. Cu(I) (Fig. 4.8), Ag(I) 
(Fig. 4.9) or Hg(II) (Fig. 4.10)  all resulted in only about a 50% reduction in the blue 
color.  We speculate that either other metal binding sites exist in azurin (vide infra) or 
that an equilibrium between Cu(II) and added metal ion occurs whereby a mix of species 
is present (vide infra). 
Table 4.1: The reduction/displacement of T1-Cu(II) at various conditions and corresponding initial 
reduction/T1 Cu(II) displacement rates. 
T1 Cu(II) reduction/displacement conditions 
Initial reduction/ Cu(II) 
displacement 
rate (mM-Az min-1) 
T1 Cu(II) reduced with 0.5 eq. ascorbic acid 
(Fig. 4.5) 0.0070 
T1 Cu(II) with 1 eq. extra Cu(II), reduced with 
0.5 eq. ascorbic Acid  
(Fig. 4.7) 
0.3501 
T1 Cu(II) displaced with 1 eq. extra Cu(I)  
(Fig. 4.8) 0.0510 
T1 Cu(II) displaced with 1eq. AgNO3 
 (Fig. 4.9) 0.1018 
T1 Cu(II) displaced with 1eq. HgCl2  
(Fig. 4.10) 0.0200 
 
  We further examined the hypothesis of mercury and silver ion displacement with 
related displacement studies. Addition of 5 eq. of Ag(I) to Cu(II) azurin in both anaerobic 
and aerobic conditions resulted in the complete loss of blue color (absorbance at 625 nm) 
in potassium phosphate buffer at pH 6.35 (Fig. 4.11). Displaced ions were removed with 
PD-10 desalting columns. Similarly, 5 eq. each of pre-reduced Cu(I) under anaerobic 
conditions (Fig. 4.12) and 5 eq. of Hg(II) (Figure not shown) were added to Cu(II) azurin 
samples. The blue color disappeared completely. These samples were then exposed to 
atmospheric oxygen. The samples in which T1-Cu(II) was displaced with Ag(I) and 
Hg(II) never returned blue suggesting that the T1 copper was displaced. However, the 
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Fig. 4.11: T1 Cu(II) displaced with 5 eq. of 
Ag(I). The arrow shows the point where Ag(I) 
was added.   
Fig. 4.12: T1 Cu(II) displaced with 5 eq Cu(I). 
The arrow shows the point where Cu(I) was 
added.     
sample in which T1-Cu(II) was exchanged with Cu(I) reappeared blue when exposed to 
oxygen.  
  
 
 
 
 
 
 
 
 
 
In further studies, the samples prepared with T1-Ag(I) and T1-Hg(II)  were 
titrated with 5 eq. of Cu(II) in phosphate buffer pH 6.35 and exposed to oxygen. The 
samples did not result in the return of blue color, even upon days of incubation and 
addition of further equivalents of Cu(II) ions. However, the titration of T1-Ag(I) and T1-
Hg(II) azurin samples with a pre-reduced Cu(I) solution in an anaerobic environment did 
result in metal ion exchange. After desalting these samples, exposure of the protein 
solution to the atmospheric oxygen yielded the return of blue color.  This indicated that 
not only does Ag(I), Hg(II), and Cu(I) displace Cu(II) in azurin, but Ag(I) and Hg(II) can 
also be displaced by Cu(I). 
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4.4.3: ESI-MS results: 
ESI mass spectra of the samples used in the assays above were obtained to 
confirm the metal binding and the mass of azurin (Fig. 4.13).  All spectra yielded masses 
that matched theory with an error of less than 0.03%. In addition, most spectra have 
adducts corresponding to masses with one Na+, K+, or Cu(II) ion, likely as a result of 
these residual ions in buffers and/or the instrument.   
The theoretical and experimental masses are summarized in Table 4.2.  
Table 4.2: List of mass peaks identified in Fig. 4.13: 
MS Spectra Peaks 
Experimental Mass 
(Da) 
Theoretical Mass 
(Da) 
Apo-azurin (Apo-WT) 13943 13943 
WT azurin + Na+ 13964 13965 
WT azurin + K+ 13977 13981 
Cu(II) WT azurin 14006 14006 
2xCu(II) WT azurin 14066 14068 
2xAg(I) WT azurin 14156 14157 
3xAg(I) WT azurin 14263 14266 
Ag(I) WT azurin + Cu(I) 14112 14112 
Hg(II) WT azurin 14141 14142 
Hg(II) WT azurin + Cu(I) 14203 14205 
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Fig. 4.13: Mass spectra of Azurin: (A): Apo Azurin, (B): T1-Cu(II), (C): T1-Ag(I), (D): T1-Cu(II) 
displaced by Ag(I), (E): T1-Ag(I) displaced by Cu(I), (F): T1-Hg(II) (G): T1-Cu(II) displaced by Hg(II) 
(H): T1-Hg(II) displaced by Cu(I). 
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       Apo azurin and Cu(II) azurin yielded masses as expected (Fig. 4.13 A and B).  As 
further controls we prepared samples of pure Hg(II) and Ag(I) substituted azurin (Fig. 
4.13 C and F). The prepared Ag(I) azurin sample had peaks corresponding to +2 Ag(I) 
and +3 Ag(I) ions, in addition to a residual +Cu(II) peak, that must have been a result of 
the residual copper in the buffer or instruments, since all samples were colorless (Fig. 
4.13 C).  The mass spectrum of prepared Hg(II) azurin sample indicated a singly bound 
Hg(II) azurin species, as well as a residual +Cu(II) peak (Fig. 4.13 F) with +Na and +K 
adducts. The Hg(II) azurin sample prepared by the displacement of T1-Cu(II) with 5 eq. 
Hg(II), showed the same two peaks in the mass spectrum, but with a larger presence of 
copper in the sample (Fig. 4.13 G). This was evidence supporting the UV-Vis data, which 
shows that T1-Cu(II) was not displaced completely by Hg(II) but formed an equilibrium 
with about half of T1-Cu(II) displaced. This result is also consistent with the mass 
spectrum of the sample where T1-Hg(II) azurin was displaced by Cu(I), where the 
resulting sample turned blue upon the exposure to oxygen. The mass spectrum of this 
sample (Fig. 4.13 H) showed major peaks at m/z of azurin +Cu(II) (~14006), azurin with 
Hg(II) (~14141) and azurin with both Hg(II) and Cu(II) (~14203). This again confirmed 
the presence of Cu(II) and Hg(II), and that both Cu(I) and Hg(II) can displace Cu(II) to 
form an equilibrium . 
  Unlike the apo-azurin sample titration yielding a single Hg(II) bound protein, the 
apo-azurin sample titrated with Ag(I) shows major peaks corresponding to azurin with 
+2Ag(I) (~14156) and azurin with +3Ag(I) (~14263) indicating up to three silver ions 
bound to azurin (Fig. 13 C). The presence of more than one Ag(II) bound to azurin is also 
seen in the mass spectrum of the azurin sample generated by displacing the Cu(II) ion 
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with 5 eq. of Ag(I) ion (Fig 4.13 D). This sample had major peaks with +2 Ag(I) 
(~14156). The deconvoluted average spectrum of this sample doesn’t show any +Cu(II) 
peak due to the presence of only negligible amount of residual Cu(II) from buffer and the 
instrument, which was too small to give a visible peak, and was omitted by the 
deconvolution software. This result indicates that almost all of T1-Cu(II) was displaced 
by Ag(I) (Fig. 4.13 D).  The mass spectrum of the sample where T1-Ag(I) was displaced 
by Cu(I), and that turned blue upon oxygen exposure, shows the presence of a major peak 
for the Cu(II) azurin (~14006) and also a minor peak for azurin with +2Cu, but doesn’t 
show any +Ag peak (Fig. 4.13 E), indicating the complete displacement of Ag(I) from T1 
site. 
 It is not clear whether the binding of multiple Ag(I) occurs in the T1 site of azurin 
as in CuA azurin(12,13) or one of the Ag(I) binds to the surface site  of azurin containing 
sulfur rich amino acid residues. Panzner et al. also observed the Ag(I) metallation of 
copper-azurin before(4) in which the absorbance of azurin decreased by about 40%, and 
the mass spectra showed adducts with +2 Ag(I).  In addition, the crystal structure of a 
Hg(II) soaked azurin (PDB Id: 4JKN), shows an additional mercury binding site (Fig. 
4.14).(9) Excess Hg(II) ions bound to a surface residue Met56 in azurin with partial 
occupancy in a methionine rich region of the protein, which caused coordination to 
another azurin protein in the unit cell creating a binding pocket for the mercury (Fig 
4.15).(9) The crystal structure of silver soaked azurin (PDB ID: 3UGE), however, doesn’t 
show any Ag(I) bound to the Met56 or any other cysteine or methionine residues apart 
from the T1 center. 
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Fig. 4.14: Image of one monomer 
of Hg(II) bound azurin showing 
the additional Hg(II) binding site. 
Fig. 4.15: Image of 
Hg(II) bound with 
Met56 
Fig. 4.16: Image of 
Ag(I) bound azurin 
 
 
 
 
 
 
 
 
 
 
4.5: Conclusion:             
The T1 site of azurin contains cysteine (Cys 112) and methionine (Met121) 
residues. Cysteine and methionine are well known Ag(I) and Hg(II) binding amino acids 
due to presence of soft Lewis base sulfur groups.[9] Our results suggest that the 
displacement of T1-Cu(II) by Hg(II) or Ag(I) is possible. The displacement of the harder 
Lewis acid Cu(II) metal ion from the metalloprotein, and hence inhibition of the protein 
activity by redox inactive ions, could indeed be an contributing factor to the toxicity of 
silver and mercury.  
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Chapter 5: Conclusions and Future Directions: 
 
We were successfully able to create functional mimics of the enzyme NiR using 
the electron transfer protein azurin as a scaffold. UV-Vis and EPR spectroscopy was used 
to characterize the variants and results were comparable to the native NiR. The activity 
assays show the nitrite reductase activity of our variants in addition to showing that the 
electron transport takes place from T1 to T2 sites. The variants we created were studied 
using Michaelis-Menten kinetics. Among the first generation variants, NiR3His-Az and 
PHM3His-Az were the most active, showing the importance of the third histidine residue 
which helps in better copper(II) binding. Second generation single mutant variants were 
created as an attempt to improve the activity of first generation variants by lowering the 
reduction potential of T1 site using Phe114Pro or Met121Gln mutants or by providing a 
direct electron transport pathway between T1 and T2 sites using the Phe15Trp mutation. 
The results from the nitrite reduction assays of NiR3His-Az and NiR-Az second 
generation single mutant variants show about the same activity as their 1st generation 
variants (NiR3His-Az or NiR-Az). Possible explanations could be that the catalytic T2 
Cu(II) site acts independently of T1 Cu(II) site or the reduction of the T1 and T2 Cu(II) 
sites is not rate limiting. The second generation double mutant variants were created by 
coupling the mutations done on the first generation variants to either lower the reduction 
potential of T1 Cu(II) site by 2 fold (Phe114Pro/Met121Gln) or provide the electron 
transport pathway between T1 and T2 Cu(II) sites while also lowering the reduction 
potential of T1 Cu(II) site (Phe15Trp/Phe114Pro and Phe15Trp/Met121Gln). The second 
generation double mutant variants were expected to further improve the activity of the 
first and second generation single mutant variants. The double mutant variants of the 
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NiR3His-Az, containing the mutation to provide direct electron transport pathway 
between T1 and T2 Cu(II) sites along with lowering the reduction potential show the 
improvement on activity by as much as 3 fold whereas the decreasing the reduction 
potential by two fold do not show much improvement. 
Reduction and re-oxidation of T1 site show the electron transport between T1 and 
T2 sites and also show difference in the reduction/re-oxidation rates of each variant 
supporting the rate limiting reduction of nitrite and the faster reduction of azurin. The 
order of reaction between azurin variants with various concentration of ascorbic acid used 
for the reduction was found to be 1st order with respect to azurin and half order with 
respect to ascorbic acid. The order of the reaction between azurin and NO2- was found to 
be pseudo 1st order. The re-oxidation with nitrite was not seen on the variants involving 
the Phe114Pro mutations possibly due to the Phe114Pro mutation breaking the hydrogen 
bond between Phe114 and Cys112 residues and affecting the electron transport between 
T1 and T2 sites.  
The metal exchange properties of wild type azurin were studied. The results show 
that the T1 Cu(II), can be displaced by either Ag(I), Hg(II) or Cu(I). Furthermore, T1 
Ag(I) or Hg(II) can also be displaced by Cu(I). The results from ESI-MS show that more 
than one Ag(I) bind to azurin whereas Hg(II) forms an equilibrium with T1 Cu(II) while 
binding with azurin. Whether these have more than one metal ion bound to the T1 active 
site or to other sulfur rich surface binding sites on azurin is not yet known. 
The next steps will be to continue characterizing the remaining second generation 
single and double mutant variants of NiR-Az, PHM-Az and PHM3His-Az for their NO2- 
reduction activities using Griess assay as well as the electron transport properties 
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using single turnover of reduction and re-oxidation. These assays will be used to 
understand the mechanism of nitrite reduction in these variants more clearly. Comparison 
of these NO2- reduction activities along with the reduction and T1 re-oxidation assays 
with the single and double mutant variants of NiR-Az, PHM-Az and PHM3His-Az could 
give more insight into the role that each mutation plays in the activities of nitrite 
reduction and re-oxidation of T1 site of the azurin variants. Finding the activities of the 
2nd generation variants of these parent variants could be used to compare the results to the 
NiR3His-Az 2nd generation variants to find the pattern of the mutations on different 
variants.  
In addition, other factors that could affect the rate of nitrite reduction and give 
insight into the mechanism of enzymes are being studied in our lab to understand the 
mechanism better. Recently, we are exploring the possibility of the bidirectional behavior 
of our variants that could also catalyze the reverse reaction of nitrite reduction (i.e. 
oxidation of NO to NO2-) to understand the mechanism of our variants better.  
 We will also look to improve the nitrite binding and the nitrite reduction 
activities by creating third generation variants. 
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